<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Glob Health</journal-id><journal-id journal-id-type="iso-abbrev">J Glob Health</journal-id><journal-id journal-id-type="publisher-id">JGH</journal-id><journal-title-group><journal-title>Journal of Global Health</journal-title></journal-title-group><issn pub-type="ppub">2047-2978</issn><issn pub-type="epub">2047-2986</issn><publisher><publisher-name>Edinburgh University Global Health Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6642815</article-id><article-id pub-id-type="publisher-id">jogh-09-020408</article-id><article-id pub-id-type="doi">10.7189/jogh.09.020408</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Epidemiology of <italic>Treponema pallidum</italic>, <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, <italic>Trichomonas vaginalis</italic>, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics</article-title><alt-title alt-title-type="running-head">Chemaitelly et al. Epidemiology of sexually transmitted infections in female sex workers in Africa</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chemaitelly</surname><given-names>Hiam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Weiss</surname><given-names>Helen A</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smolak</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Majed</surname><given-names>Elzahraa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abu-Raddad</surname><given-names>Laith J</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><aff id="aff1"><label>1</label>Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation &#x02013; Education City, Doha, Qatar</aff><aff id="aff2"><label>2</label>MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom</aff><aff id="aff3"><label>3</label>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom</aff><aff id="aff4"><label>4</label>Department of Healthcare Policy &#x00026; Research, Weill Cornell Medicine, Cornell University, New York, New York, USA</aff><aff id="aff5"><label>5</label>College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar</aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence to:</bold>&#x02028;Hiam Chemaitelly&#x02028;Weill Cornell Medicine-Qatar&#x02028;Qatar Foundation-Education City&#x02028;P.O. Box 24144&#x02028;Doha&#x02028;Qatar&#x02028;<email xlink:href="hsc2001@qatar-med.cornell.edu">hsc2001@qatar-med.cornell.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="print"><month>12</month><year>2019</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>7</month><year>2019</year></pub-date><volume>9</volume><issue>2</issue><elocation-id>020408</elocation-id><permissions><copyright-statement>Copyright &#x000a9; 2019 by the Journal of Global Health. All rights reserved.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p></license></permissions><abstract><sec><title>Background</title><p>The epidemiology of sexually transmitted infections (STIs) and the role of commercial heterosexual sex networks in driving STI transmission in the Middle East and North Africa (MENA) region remain largely unknown.</p></sec><sec><title>Objective</title><p>To characterize the epidemiology of <italic>Treponema pallidum</italic> (syphilis), <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, <italic>Trichomonas vaginalis</italic>, and herpes simplex virus type 2 (HSV-2) among female sex workers (FSWs) in MENA using an in-depth quantitative assessment.</p></sec><sec><title>Methods</title><p>A systematic review on ten international, regional, and country-level databases was conducted, and reported following PRISMA guidelines. Pooled prevalences of current and/or ever infection for each STI were estimated using random-effects meta-analyses. Sources of between-study heterogeneity were investigated through random-effects meta-regressions.</p></sec><sec><title>Results</title><p>One <italic>T. pallidum</italic> incidence study and 144 STI prevalence studies were identified for 45&#x02009;812 FSWs in 13 MENA countries. The pooled prevalence of current infection was 12.7% (95% confidence interval (CI)&#x02009;=&#x02009;8.5%-17.7%) for <italic>T. pallidum</italic>, 14.4% (95% CI&#x02009;=&#x02009;8.2%-22.0%) for <italic>C. trachomatis</italic>, 5.7% (95% CI&#x02009;=&#x02009;3.5%-8.4%) for <italic>N. gonorrhoeae</italic>, and 7.1% (95% CI&#x02009;=&#x02009;4.3%-10.5%) for <italic>T. vaginalis</italic>. The pooled prevalence of ever infection (seropositivity using antibody testing) was 12.8% (95% CI&#x02009;=&#x02009;9.4%-16.6%) for <italic>T. pallidum</italic>, 80.3% (95% CI&#x02009;=&#x02009;53.2%-97.6%) for <italic>C. trachomatis</italic>, and 23.7% (95% CI&#x02009;=&#x02009;10.2%-40.4%) for HSV-2. The multivariable meta-regression for <italic>T. pallidum</italic> infection demonstrated strong subregional differences, with the Horn of Africa and North Africa showing, respectively 6-fold (adjusted odds ratio (AOR): 6.4; 95% CI&#x02009;=&#x02009;2.5-16.7) and 5-fold (AOR&#x02009;=&#x02009;5.0; 95% CI&#x02009;=&#x02009;2.5-10.6) higher odds of infection than Eastern MENA. There was also strong evidence for declining <italic>T. pallidum</italic> odds of infection at 7% per year (AOR&#x02009;=&#x02009;0.93; 95% CI&#x02009;=&#x02009;0.88-0.98). Study-specific factors including diagnostic method, sample size, sampling methodology, and response rate, were not associated with syphilis infection. The multivariable model explained 48.5% of the variation in <italic>T. pallidum</italic> prevalence.</p></sec><sec><title>Conclusions</title><p>STI infection levels among FSWs in MENA are considerable, supporting a key role for commercial heterosexual sex networks in transmission dynamics, and highlighting the health needs of this neglected and vulnerable population. Syphilis prevalence in FSWs appears to have been declining for at least three decades. Gaps in evidence persist for multiple countries.</p></sec></abstract><counts><fig-count count="1"/><table-count count="5"/><equation-count count="0"/><ref-count count="126"/><page-count count="20"/></counts></article-meta></front><body><p>The burden of sexually transmitted infections (STIs) and sequelae remains a major global health concern [<xref rid="R1" ref-type="bibr">1</xref>]. Nearly one million persons are infected with a curable STI every day [<xref rid="R2" ref-type="bibr">2</xref>], and about half a billion are living with herpes simplex virus type 2 (HSV-2) [<xref rid="R3" ref-type="bibr">3</xref>]. The largely asymptomatic nature of STIs, particularly for women, leaves most individuals unaware of their infection [<xref rid="R1" ref-type="bibr">1</xref>]. STIs have been associated with HIV acquisition [<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>], and poor reproductive health outcomes including pelvic inflammatory disease, ectopic pregnancy, infertility, and perinatal deaths [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R7" ref-type="bibr">7</xref>].</p><p>Commercial heterosexual sex networks (CHSNs) are believed to play a critical role in STI transmission [<xref rid="R8" ref-type="bibr">8</xref>-<xref rid="R10" ref-type="bibr">10</xref>]. STIs have been demonstrated as proxy biomarkers of sexual risk behaviour [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>], and as a powerful tool for understanding the structure of sexual networks and predicting HIV epidemic potential [<xref rid="R11" ref-type="bibr">11</xref>-<xref rid="R13" ref-type="bibr">13</xref>]. However, unlike HIV, STI epidemiology in CHSNs remains, globally, a neglected area of research [<xref rid="R1" ref-type="bibr">1</xref>]. Programmatically, STI surveillance among female sex workers (FSWs) continues to be weak and infection levels poorly quantified [<xref rid="R1" ref-type="bibr">1</xref>]. Sexual propagation of STIs along CHSNs is also poorly understood given the dearth or limited validity of self-reported sexual behaviour data [<xref rid="R13" ref-type="bibr">13</xref>-<xref rid="R15" ref-type="bibr">15</xref>].</p><p>To attend to the United Nations&#x02019; Sustainable Development Goals (SDGs) and targets [<xref rid="R16" ref-type="bibr">16</xref>], particularly SDG3 target of &#x0201c;ensuring universal access to sexual and reproductive health services&#x0201d; [<xref rid="R16" ref-type="bibr">16</xref>], and to reduce the global burden of disease attributed to STIs, the World Health Organization (WHO) has recently formulated the &#x0201c;Global Health Sector Strategy on STIs&#x0201d; [<xref rid="R6" ref-type="bibr">6</xref>]. The goal of this strategy is to eliminate STIs as a major public health concern by 2030 through an integrated approach for prevention and control [<xref rid="R6" ref-type="bibr">6</xref>]. Milestones for 2020 include achieving 70% coverage for comprehensive STI prevention services among key populations [<xref rid="R6" ref-type="bibr">6</xref>]. The strategy&#x02019;s first strategic direction entails &#x0201c;understanding the STI epidemic as a basis for advocacy, political commitment, national planning, resource mobilization and allocation, implementation, and programme improvement&#x0201d; [<xref rid="R6" ref-type="bibr">6</xref>].</p><p>Despite remarkable progress in HIV research [<xref rid="R17" ref-type="bibr">17</xref>], and an understanding of the role of FSWs [<xref rid="R18" ref-type="bibr">18</xref>], people who inject drugs (PWID) [<xref rid="R19" ref-type="bibr">19</xref>], and men who have sex with men (MSM) [<xref rid="R20" ref-type="bibr">20</xref>], in the HIV epidemic in the Middle East and North Africa (MENA) region, the epidemiology of STIs and the role of CHSNs in driving STI transmission remain largely unknown [<xref rid="R21" ref-type="bibr">21</xref>]. The two global reviews of STI epidemiology in FSWs had no data for any of the 23 MENA countries [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]. A large volume of STI data in the region resides in databases that were never analyzed, or in country-level reports that were never published in the scientific literature [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>].</p><p>Against this background, our study aimed to characterize the epidemiology of key STIs among FSWs in MENA by 1) systematically reviewing and synthesizing all available published and unpublished evidence for <italic>Treponema pallidum</italic> (henceforth referred to as syphilis), <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, <italic>Trichomonas vaginalis</italic>, and HSV-2 incidence and/or prevalence, 2) estimating, for each STI, the pooled mean prevalence of current and/or ever (seropositivity using antibody testing) infection, and 3) identifying sources of between-study heterogeneity, and regional and temporal trends associated with STI prevalence.</p><sec sec-type="methods"><title>METHODS</title><p>We conducted a systematic review and an in-depth quantitative assessment to characterize STI epidemiology among FSWs in MENA. Details of the study methodology (including specific statistical analyses) can be found in subsequent sections.</p><sec><title>Search strategy and selection criteria</title><p>Evidence for syphilis, <italic>C. trachomatis</italic>, <italic>N. gonorrhaoeae</italic>, <italic>T. vaginalis</italic>, and HSV-2 immunoglobulin G (IgG) incidence and/or prevalence among FSWs in MENA was systematically reviewed, informed by Cochrane&#x02019;s Collaboration guidelines [<xref rid="R26" ref-type="bibr">26</xref>]. Findings were reported following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines [<xref rid="R27" ref-type="bibr">27</xref>] (checklist in Table S1 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>). The MENA definition covers 23 countries&#x02014;Afghanistan, Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates (UAE), and Yemen&#x02014;based on convention in HIV research [<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>], and definitions of WHO, Joint United Nations Programme on HIV/AIDS (UNAIDS), and World Bank [<xref rid="R24" ref-type="bibr">24</xref>].</p><p>Systematic searches were performed up to September 20, 2018, on international databases (PubMed and Embase), regional and national databases (WHO Global Health Observatory data repository [<xref rid="R28" ref-type="bibr">28</xref>], WHO African Index Medicus database, WHO Index Medicus for the Eastern Mediterranean Region database, Iranian Scientific Information Database, Iraqi Academic Scientific Journals&#x02019; database, and Pakistan&#x02019;s PakMediNet database), abstract archives of International AIDS Society Conferences [<xref rid="R29" ref-type="bibr">29</xref>], as well as published and unpublished country-level and international organizations&#x02019; reports available through the MENA HIV/AIDS Epidemiology Synthesis Project database [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>]. Search strings were broad (MeSH/Emtree terms exploded to cover all subheadings and free text terms) with no language or year restrictions (Box S1 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>).</p><p>Duplicate citations were identified using a reference manager, Endnote. Titles and abstracts were then screened for relevance, with relevant/potentially relevant citations undergoing full-text screening. Any document reporting an incidence and/or prevalence measure in FSWs for an STI of interest, based on primary data, was eligible for inclusion. Case reports, case series, editorials, commentaries, and reviews were excluded. Hand searching was further performed on reference lists of all relevant articles.</p><p>The term <italic>&#x02018;study&#x02019;</italic> is used here to refer to a specific STI incidence or prevalence measure in a specific FSW population. Accordingly, one document/report could contribute multiple studies and one study could be published in different reports. Duplicate study results were included only once using the more detailed/recent report.</p></sec><sec><title>Data extraction and synthesis</title><p>Extraction was performed by HC, and double extraction by AS (extraction list in Box S2 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>). Discrepancies were settled by consensus, or by contacting authors. Full-texts in languages other than English were extracted by native speakers. Data were stratified by infection type (current vs ever (seropositivity using antibody testing)), and summarized using medians, ranges, and interquartile ranges (IQR). Definitions of infection types and details of the classification of diagnostic methods&#x02019; results into current, recent, and ever infection can be found in Table S2 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>. It was assumed, for <italic>N. gonorrhoeae</italic> and <italic>T. vaginalis</italic> studies, whenever a diagnostic method was not explicitly specified, that the diagnostic method assessed current infection.</p><p>All STI studies were extracted and reported. However, studies applying the same assay to different biological specimens from the same person were included only once in analyses, for statistical independence. This was done based on a sequential order that prioritized infection detection in endocervical swabs, followed by vaginal, then urine samples. Studies assessing prevalence using different diagnostic methods, were also included only once in analyses, with studies using polymerase chain reaction prioritized over those using culture or other methods.</p></sec><sec><title>Quality assessment</title><p>The quality assessment for each STI prevalence study was informed by Cochrane Collaboration guidelines (criteria in Table S3 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>) [<xref rid="R30" ref-type="bibr">30</xref>]. Studies were classified as having &#x0201c;low&#x0201d; vs &#x0201c;high&#x0201d; risk of bias (ROB) on each of three quality domains assessing the 1) rigor of sampling methodology (probability-based; non-probability-based), 2) response rate (&#x02265;60% or &#x02265;60% of target sample size reached for studies using respondent-driven or time-location sampling; &#x0003c;60%), and 3) STI ascertainment (biological assay explicitly indicated; otherwise). Studies with missing information for a specific domain were classified as having &#x0201c;unclear&#x0201d; ROB for that domain.</p><p>Given reported limitations in HSV-2 diagnostics [<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>], the quality of HSV-2 assays was determined by consulting with an expert advisor, Professor Rhoda Ashley-Morrow, University of Washington, Seattle. Studies where the validity of the diagnostic method could not be confirmed, were excluded from the systematic review.</p><p>Quality domains were included in meta-regression analyses (described below) to assess their impact on prevalence.</p></sec><sec><title>Meta-analyses</title><p>For each STI, the pooled mean prevalence of current and/or ever infection, along with the corresponding 95% confidence intervals (CIs), were estimated using meta-analysis. Overall prevalence measures were replaced by their strata where applicable. For each study, one final stratification was considered based on a pre-defined sequential order that prioritizes country of origin, followed by type of FSW, year, region, and age. Subregional and time-trend analyses were conducted as warranted by data. Variances were stabilized using Freeman-Tukey type arcsine square-root transformation [<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>]. Weights were applied using the inverse-variance method [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>], before pooling measures using a Dersimonian-Laird random-effects model [<xref rid="R36" ref-type="bibr">36</xref>], thereby accounting for sampling variation and for true heterogeneity [<xref rid="R37" ref-type="bibr">37</xref>]. Missing sample sizes for measures or their strata (&#x0003c;4% of all studies) were imputed using the median sample size, as calculated from studies with available information.</p><p>Heterogeneity assessment used Cochran&#x02019;s Q statistic to confirm existence of heterogeneity across studies, I<sup>2</sup> to determine magnitude of between-study variation that is due to true differences in effect size (prevalence) rather than chance, and prediction intervals to estimate the 95% interval of the true effect sizes&#x02019; distribution [<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>].</p><p>Meta-analyses were implemented in R 3.4.2 (R core team, Vienna, Austria) [<xref rid="R39" ref-type="bibr">39</xref>].</p></sec><sec><title>Meta-regressions</title><p>Only syphilis had a considerable number of measures (&#x0003e;100) to warrant conduct of random-effects meta-regression analyses. Independent variables considered <italic>a priori</italic> were: country/subregion, year of data collection, infection type, diagnostic method, STI ascertainment, sample size, sampling methodology, and response rate. Details of subgrouping and justifications are in Table S4 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>. Meta-regression was conducted using the log-transformed odds of syphilis infection and corresponding variance. Factors associated with higher odds of infection at <italic>P</italic>&#x02009;&#x02264;&#x02009;0.10 in univariable analyses were included in the multivariable analysis. Factors with <italic>P</italic>&#x02009;&#x02264;&#x02009;0.05 in the multivariable model were considered as significant predictors of heterogeneity in syphilis prevalence.</p><p>Meta-regressions were implemented in Stata/SE 15.1 (StataCorp, College Station, TX, USA) [<xref rid="R40" ref-type="bibr">40</xref>].</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Search results and scope of evidence</title><p><xref ref-type="fig" rid="F1"><bold>Figure 1</bold></xref> shows the study selection process based on PRISMA. The search identified a total of 11&#x02009;832 citations: 240 through PubMed, 1949 through Embase, and 9643 through the rest of the databases. After removing duplicates and screening of titles and abstracts, 157 reports qualified for full-text screening, of which 31 were eligible for inclusion in the systematic review.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart presenting the process of study selection following PRISMA guidelines [<xref rid="R27" ref-type="bibr">27</xref>].</p></caption><graphic xlink:href="jogh-09-020408-F1"/></fig><p>Thirteen additional reports, two of which replaced eligible articles, and four additional STI measures, were further identified through the MENA HIV/AIDS Epidemiology Synthesis Project database. Fourteen additional syphilis prevalence measures were identified through the WHO Global Health Observatory data repository. Two studies were excluded based on consultation with Professor Rhoda Ashley-Morrow, an expert advisor in HSV-2 diagnostics, because the validity of the type-specific HSV-2 serology could not be confirmed [<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R42" ref-type="bibr">42</xref>].</p><p>In sum, 42 eligible reports and 18 additional STI measures were included in the systematic review. These yielded one syphilis incidence study, and 144 prevalence studies assessing the different STIs. The latter contributed 173 stratified measures for inclusion in meta-analyses and meta-regressions.</p><p>STI prevalence data were available for 45&#x02009;812 FSWs from 13 of the 23 MENA countries. Nearly two-thirds (58.9%) of prevalence studies assessed syphilis (in 29&#x02009;769 FSWs), 16.3% assessed <italic>C. trachomatis</italic> (in 5613 FSWs), 12.8% assessed <italic>N. gonorrhoeae</italic> (in 5230 FSWs), 8.5% assessed <italic>T. vaginalis</italic> (in 4258 FSWs), and 3.6% assessed HSV-2 IgG (in 942 FSWs). Most studies (80.8%) were conducted post-2000. Over half (51.1%) of studies reported on current infection, 30.5% on ever infection (seropositivity using antibody testing), and 1.4% on recent infection. Time of exposure was unclear for the rest of studies (17.0%).</p></sec><sec><title>Incidence studies</title><p>The only one identified incidence study assessed syphilis incidence in FSWs. The study was conducted in 1988 in Mogadishu, Somalia, and reported cumulative incidence at 12.5% after six months of follow-up [<xref rid="R43" ref-type="bibr">43</xref>].</p></sec><sec><title>Prevalence studies</title><p>Prevalence of current syphilis infection among FSWs ranged, across studies (n&#x02009;=&#x02009;28), from 0%-50.8%, with a median of 9.4% (IQR&#x02009;=&#x02009;3.0%-23.4%; <xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>). Meanwhile, seropositivity for syphilis (n&#x02009;=&#x02009;33) antibodies ranged from 0%-69.0%, with a median of 4.2% (IQR&#x02009;=&#x02009;1.9%-15.2%).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Prevalence of syphilis among FSWs in the Middle East and North Africa*</p></caption><table frame="hsides" rules="groups"><col width="118" span="1"/><col width="59" span="1"/><col width="123" span="1"/><col width="59" span="1"/><col width="82" span="1"/><col width="92" span="1"/><col width="44" span="1"/><col width="66" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Country short citation</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year(s) of data collection</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">City/province</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sampling</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study site</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Assay type</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Tested (n)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Prevalence (%)</th></tr></thead><tbody><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>CURRENT INFECTION</bold><hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Afghanistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Todd, 2010 [<xref rid="R44" ref-type="bibr">44</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2006-08<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Jalalabad, Kabul, Mazar-i-Sharif<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NGO<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">520<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Egypt:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2000 [<xref rid="R45" ref-type="bibr">45</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1999-00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Greater Cairo<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.8<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kassaian, 2012 [<xref rid="R46" ref-type="bibr">46</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2009-10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Prison, drop-in center<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Navadeh, 2012 [<xref rid="R42" ref-type="bibr">42</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kerman<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">139<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kazerooni, 2014 [<xref rid="R41" ref-type="bibr">41</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Shiraz<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; FTA-ABS+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">278<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jahanbakhsh, 2017 [<xref rid="R47" ref-type="bibr">47</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tehran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Homeless shelters<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2008 [<xref rid="R48" ref-type="bibr">48</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir, Rabat-Sale, Tanger<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">141<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">362<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Fes<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">359<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rabat<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">392<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tanger<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">318<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.3<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Baqi, 1998 [<xref rid="R50" ref-type="bibr">50</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1993-94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Karachi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; FTA-ABS+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>] &#x00026; NACP, 2005 [<xref rid="R52" ref-type="bibr">52</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Karachi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Snowball<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">421<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>] &#x00026; NACP, 2005 [<xref rid="R52" ref-type="bibr">52</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">SyCS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">387<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Shah, 2004 [<xref rid="R53" ref-type="bibr">53</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hyderabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">157<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khan, 2011 [<xref rid="R55" ref-type="bibr">55</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">730<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.5<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Somalia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jama, 1987 [<xref rid="R56" ref-type="bibr">56</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1985-86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jama Ahmed, 1991 [<xref rid="R43" ref-type="bibr">43</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1988-89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL/RPR+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">155<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">47.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Scott, 1991 [<xref rid="R57" ref-type="bibr">57</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1989<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kismayu, Merca<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; FTA-ABS+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Corwin, 1991 [<xref rid="R58" ref-type="bibr">58</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1990<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chismayu, Merca, Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; FTA-ABS+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">302<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Watts, 1994 [<xref rid="R59" ref-type="bibr">59</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1990<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chismayu, Merca, Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RPR+ &#x00026; FTA-ABS+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">236<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">IOM, 2017 [<xref rid="R60" ref-type="bibr">60</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hargeisa<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+ &#x00026; RPR+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.4<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Sudan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2016 [<xref rid="R61" ref-type="bibr">61</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015-16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Juba, South Sudan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+ &#x00026; RPR+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">832<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.3<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bchir, 1988 [<xref rid="R62" ref-type="bibr">62</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1987<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sousse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ayachi, 1997 [<xref rid="R63" ref-type="bibr">63</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1992-94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+ &#x00026; TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24.1<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Yemen:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Stulhofer, 2008 [<xref rid="R64" ref-type="bibr">64</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Aden<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VDRL+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">244<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.9<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>EVER INFECTION&#x02021;</bold><hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Afghanistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NACP, 2010 [<xref rid="R65" ref-type="bibr">65</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2009<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kabul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">368<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NACP, 2012 [<xref rid="R66" ref-type="bibr">66</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Herat<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">344<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NACP, 2012 [<xref rid="R66" ref-type="bibr">66</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kabul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">333<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NACP, 2012 [<xref rid="R66" ref-type="bibr">66</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mazar-i-Sharif<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">355<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Algeria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2009 [<xref rid="R67" ref-type="bibr">67</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sentinel surveillance<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">185<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2009 [<xref rid="R67" ref-type="bibr">67</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sentinel surveillance<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">380<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.4<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mirzazadeh, 2016 [<xref rid="R68" ref-type="bibr">68</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community, clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1,337<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bibi, 2010 [<xref rid="R69" ref-type="bibr">69</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2003<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hyderabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Raza, 2015 [<xref rid="R70" ref-type="bibr">70</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Somalia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jama, 1987 [<xref rid="R56" ref-type="bibr">56</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1985-86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jama Ahmed, 1991 [<xref rid="R43" ref-type="bibr">43</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1988-89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">155<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">69.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Burans, 1990 [<xref rid="R71" ref-type="bibr">71</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">IOM, 2017 [<xref rid="R60" ref-type="bibr">60</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hargeisa<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">237<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.4<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Sudan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Alshamalia<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">305<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Blue Nile<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">279<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gadarif<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">282<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gezira<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">296<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kassala<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">288<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Khartoum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">287<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">North Darfur<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">303<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">North Kodofan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">296<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red Sea<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">293<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">River Nile<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">291<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sinnar<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">303<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">South Darfur<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">299<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">West Darfur<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">284<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sudan NACP, 2012 [<xref rid="R72" ref-type="bibr">72</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">White Nile<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">288<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2016 [<xref rid="R61" ref-type="bibr">61</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015-16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Juba, South Sudan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDT+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">832<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bchir, 1988 [<xref rid="R62" ref-type="bibr">62</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1987<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sousse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">38.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ayachi, 1997 [<xref rid="R63" ref-type="bibr">63</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1992-94<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TPHA+<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">183<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.7<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>UNCLEAR</bold><hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Afghanistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MENA HIV ESP, 2013 [<xref rid="R74" ref-type="bibr">74</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kabul<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">440<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2017<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2,457<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.3<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Algeria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2013<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Oran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Saida<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2016<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">183<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2017<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">VCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16.0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Djibouti:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2015 [<xref rid="R1" ref-type="bibr">1</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4 urban sites<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">361<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Moayedi-Nia, 2016 [<xref rid="R75" ref-type="bibr">75</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2012-13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tehran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">161<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Jordan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2015 [<xref rid="R1" ref-type="bibr">1</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.7<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khattabi, 2005 [<xref rid="R76" ref-type="bibr">76</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Prison<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">332<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khattabi, 2005 [<xref rid="R76" ref-type="bibr">76</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">272<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khattabi, 2005 [<xref rid="R76" ref-type="bibr">76</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Grand Casablanca<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">STI clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">143<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bennani, 2006 [<xref rid="R77" ref-type="bibr">77</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2005<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Prison<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">102<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bennani, 2006 [<xref rid="R77" ref-type="bibr">77</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2005<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">143<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16.9<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MENA HIV ESP, 2010 [<xref rid="R24" ref-type="bibr">24</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23.5<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Somalia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2017<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Bossaso, Hargeisa, Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">860<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.7<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Sudan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2016<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4,123<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2017<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">South Sudan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1,244<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.4<hr/></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Yemen:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO, 2018 [<xref rid="R28" ref-type="bibr">28</xref>]</td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">Hodeida</td><td valign="top" align="center" rowspan="1" colspan="1">RDS</td><td valign="top" align="center" rowspan="1" colspan="1">Community</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">301</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><p>Conv &#x02013; convenience, FTA-ABS &#x02013; fluoresceent treponemal antibody absorption test, IOM &#x02013; International Organization for Migration, MENA HIV ESP &#x02013; MENA HIV/AIDS Epidemiology Synthesis Project database, MOH &#x02013; Ministry of Health, NACP &#x02013; National AIDS Control Program, NGO &#x02013; non-governmental organization, NR &#x02013; not reported, RDS &#x02013; respondent-driven sampling, RDT &#x02013; rapid diagnostic test, RPR &#x02013; rapid plasma regain, STI &#x02013; sexually transmitted infection, SyCS &#x02013; systematic cluster sampling, TPHA &#x02013; <italic>Treponema pallidum</italic> haemagglutination assay, VCT &#x02013; voluntary counseling and testing center, VDRL &#x02013; venereal disease research laboratory</p><p>*The table is sorted, for each country, by data collection year(s) then city/province.</p><p>&#x02020;Sample comprised of 77 FSWs and 4 transgender women.</p><p>&#x02021;Ever infection indicates seropositivity using antibody testing.</p></table-wrap-foot></table-wrap><p>Current <italic>C. trachomatis</italic> infection prevalence (n&#x02009;=&#x02009;14) ranged from 0.7%-72.9%, with a median of 7.7% (IQR&#x02009;=&#x02009;1.7%-22.4%), while seropositivity prevalence using IgG (n&#x02009;=&#x02009;5) ranged from 19.8%-100%, with a median of 85.8% (IQR&#x02009;=&#x02009;46.8%-97.1%; <xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>). Two studies reported recent <italic>C. trachomatis</italic> infection (assessed using serological biomarkers) at 29.2% [<xref rid="R79" ref-type="bibr">79</xref>] and 95.0% [<xref rid="R78" ref-type="bibr">78</xref>].</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Prevalence of <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, and <italic>Trichomonas vaginalis</italic> among FSWs in the Middle East and North Africa*</p></caption><table frame="hsides" rules="groups"><col width="117" span="1"/><col width="49" span="1"/><col width="112" span="1"/><col width="49" span="1"/><col width="81" span="1"/><col width="89" span="1"/><col width="54" span="1"/><col width="40" span="1"/><col width="54" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Country short citation</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year(s) of data collection</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">City/province</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sampling</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study site</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Specimen</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Assay type</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Tested (n)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Prevalence (%)</th></tr></thead><tbody><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>CURRENT INFECTION</bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Chlamydia trachomatis</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Algeria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kadi, 1989 [<xref rid="R78" ref-type="bibr">78</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">IFAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">45.5<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Egypt:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2000 [<xref rid="R45" ref-type="bibr">45</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1999-00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Cairo<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.7<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Darougar, 1983 [<xref rid="R79" ref-type="bibr">79</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Bandar Abbas, Tehran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">116<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kazerooni, 2014 [<xref rid="R41" ref-type="bibr">41</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Shiraz<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">278<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mirzazadeh, 2016 [<xref rid="R68" ref-type="bibr">68</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic, community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1337<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.0<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2008 [<xref rid="R48" ref-type="bibr">48</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir, Rabat Sale, Tanger<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical &#x00026; urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">141<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">368<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.4<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Karachi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Snowball<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">348<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">SyCS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">283<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khan, 2011 [<xref rid="R55" ref-type="bibr">55</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">730<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.7<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Somalia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">IOM, 2017 [<xref rid="R60" ref-type="bibr">60</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hargeisa<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">90<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.7<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">72.9<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Neisseria gonorrhoeae</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Egypt:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2000 [<xref rid="R45" ref-type="bibr">45</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1999-00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Cairo<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.7<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kazerooni, 2014 [<xref rid="R41" ref-type="bibr">41</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Shiraz<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">278<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Navadeh, 2012 [<xref rid="R42" ref-type="bibr">42</xref>] &#x00026; WHO, 2011 [<xref rid="R80" ref-type="bibr">80</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kerman<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">144<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nasirian, 2017 [<xref rid="R81" ref-type="bibr">81</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2013-14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Harm reduction<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nasirian, 2017 [<xref rid="R81" ref-type="bibr">81</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2013-14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Harm reduction<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0&#x02021;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Taghizadeh, 2015 [<xref rid="R82" ref-type="bibr">82</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sari<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drop-in center<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">117<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mirzazadeh, 2016 [<xref rid="R68" ref-type="bibr">68</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic, community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1337<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.3<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2008 [<xref rid="R48" ref-type="bibr">48</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir, Rabat Sale, Tanger<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical &#x00026; urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">141<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MENA HIV ESP, 2010 [<xref rid="R24" ref-type="bibr">24</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.5<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">368<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.7<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Karachi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Snowball<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">348<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">SyCS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">383<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khan, 2011 [<xref rid="R55" ref-type="bibr">55</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">730<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.5<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Somalia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Burans, 1990 [<xref rid="R71" ref-type="bibr">71</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Mogadishu<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">IOM, 2017 [<xref rid="R60" ref-type="bibr">60</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2014<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Hargeisa<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NACP, 2005 [<xref rid="R83" ref-type="bibr">83</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2005<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.0-17.0&#x000a7;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.7&#x02016;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.2<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Trichomonas vaginalis</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Egypt:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2000 [<xref rid="R45" ref-type="bibr">45</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1999-00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Cairo<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.2<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Vafaei, 2015 [<xref rid="R84" ref-type="bibr">84</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2009-11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Shiraz<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic, drop-in center<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Wet mount<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Navadeh, 2012 [<xref rid="R42" ref-type="bibr">42</xref>] &#x00026; WHO, 2011 [<xref rid="R80" ref-type="bibr">80</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kerman<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">144<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nasirian, 2017 [<xref rid="R81" ref-type="bibr">81</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2013-14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Harm reduction<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nasirian, 2017 [<xref rid="R81" ref-type="bibr">81</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2013-14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Harm reduction<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Urine<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0&#x02021;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mirzazadeh, 2016 [<xref rid="R68" ref-type="bibr">68</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2015<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">National<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic, community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1337<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.9<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2008 [<xref rid="R48" ref-type="bibr">48</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir, Rabat Sale, Tanger<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Endocervical &#x00026; vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">141<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.9<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MOH, 2012 [<xref rid="R49" ref-type="bibr">49</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2011-12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Agadir<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">367<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.8<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Karachi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Snowball<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">386<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rehan, 2009 [<xref rid="R51" ref-type="bibr">51</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2004<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">SyCS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Red-light district<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">384<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NAAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.3<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Khan, 2011 [<xref rid="R55" ref-type="bibr">55</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lahore<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Vaginal<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Culture<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">730<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.1<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>RECENT INFECTION</bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Chlamydia trachomatis</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Algeria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kadi, 1989 [<xref rid="R78" ref-type="bibr">78</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF&#x0003e;1:64&#x000b6;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.0<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Darougar, 1983 [<xref rid="R79" ref-type="bibr">79</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Bandar Abbas, Tehran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF-IgM<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">154<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29.2<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>EVER INFECTION</bold>**<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Chlamydia trachomatis</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Algeria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kadi, 1989 [<xref rid="R78" ref-type="bibr">78</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">100<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Darougar, 1983 [<xref rid="R79" ref-type="bibr">79</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Bandar Abbas, Tehran<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">154<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">94.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kassaian, 2012 [<xref rid="R46" ref-type="bibr">46</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2009-10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Isfahan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drop-in center<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">ELISA-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.8<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bchir, 1988 [<xref rid="R62" ref-type="bibr">62</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1987<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Sousse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF&#x0003e;1:16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">73.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Clinic<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MIF-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">183<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85.8<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>UNCLEAR:</bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold><italic>Chlamydia trachomatis</italic></bold><hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Iran:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Navadeh, 2012 [<xref rid="R42" ref-type="bibr">42</xref>] &#x00026; WHO, 2011 [<xref rid="R80" ref-type="bibr">80</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2010<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Kerman<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">NR<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">144<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.9<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Morocco:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">MENA HIV ESP, 2010 [<xref rid="R24" ref-type="bibr">24</xref>]</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">19.1</td></tr></tbody></table><table-wrap-foot><p>Conv &#x02013; convenience, ELISA &#x02013; enzyme-linked immunosorbent assay, IFAT &#x02013; indirect immunofluorescence antibody test, IgG &#x02013; immuneglobulin G, IgM - immunoglobulin M, IOM &#x02013; International Organization for Migration, MENA HIV ESP &#x02013; MENA HIV/AIDS Epidemiology Synthesis Project database, MIF &#x02013; micro-immunofluorescence, MOH &#x02013; Ministry of Health, NAAT &#x02013; Nucleic acid amplification test, NR &#x02013; not reported, RDS &#x02013; respondent-driven sampling, SyCS &#x02013; systematic cluster sampling, WHO &#x02013; World Health Organization</p><p>*The table is sorted for each country by data collection year(s) then city/province.</p><p>&#x02020;For <italic>Neisseria gonorrhoeae</italic> and <italic>Trichomonas vaginalis</italic> studies, whenever the diagnostic method was not explicitly specified, it was assumed that the diagnostic method assessed current infection.</p><p>&#x02021;Studies reported in the systematic review, but not included in analyses considering the priority order followed for selecting studies applying the same assay to different biological specimens.</p><p>&#x000a7;Range reported based on several studies whose abstracts or full-texts could not be retrieved (mid-point: 14.5%).</p><p>&#x02016;Studies reported in the systematic review, but not included in analyses as prevalence was also assessed using NAAT.</p><p>&#x000b6;Reported in study as recent infection.</p><p>**Ever infection indicates seropositivity using antibody testing.</p></table-wrap-foot></table-wrap><p>Current <italic>N. gonorrhoeae</italic> infection prevalence (n&#x02009;=&#x02009;18) ranged from 0%-14.5%, with a median of 7.6% (IQR&#x02009;=&#x02009;1.3%-11.1%; <xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>). Current <italic>T. vaginalis</italic> infection prevalence (n&#x02009;=&#x02009;12) ranged from 0%-19.3%, with a median of 7.0% (IQR&#x02009;=&#x02009;4.5%-14.2%; <xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>). HSV-2 seropositivity (using IgG; n&#x02009;=&#x02009;5) ranged from 4.7%-55.5%, with a median of 20.0% (IQR&#x02009;=&#x02009;6.4%-39.1%; <xref rid="T3" ref-type="table"><bold>Table 3</bold></xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Prevalence of herpes simplex virus type 2 (HSV-2) immunoglobulin G (IgG) sero-markers among FSWs in the Middle East and North Africa</p></caption><table frame="hsides" rules="groups"><col width="92" span="1"/><col width="66" span="1"/><col width="96" span="1"/><col width="59" span="1"/><col width="101" span="1"/><col width="60" span="1"/><col width="60" span="1"/><col width="44" span="1"/><col width="66" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Country short citation</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year(s) of data collection</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">City/province</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sampling</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study site</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Specimen</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Assay type</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Tested (n)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Prevalence (%)</th></tr></thead><tbody><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Pakistan:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Abbottabad<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">ELISA-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hawkes, 2009 [<xref rid="R54" ref-type="bibr">54</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2007<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Rawalpindi<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">RDS<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Community<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">ELISA-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">426<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.0<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Syria:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ibrahim, 2000 [<xref rid="R85" ref-type="bibr">85</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1995-98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Damascus<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Cheap hotels &#x00026; prison<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MEIA-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">101<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ibrahim, 2000 [<xref rid="R85" ref-type="bibr">85</xref>]<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1995-98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Damascus<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Conv<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Bars<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Serum<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">MEIA-IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">125<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.0<hr/></td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Tunisia:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Znazen, 2010 [<xref rid="R73" ref-type="bibr">73</xref>]</td><td valign="top" align="center" rowspan="1" colspan="1">2007</td><td valign="top" align="center" rowspan="1" colspan="1">Gabes, Sousse, Tunis</td><td valign="top" align="center" rowspan="1" colspan="1">Conv</td><td valign="top" align="center" rowspan="1" colspan="1">Clinic</td><td valign="top" align="center" rowspan="1" colspan="1">Serum</td><td valign="top" align="center" rowspan="1" colspan="1">ELISA-IgG</td><td valign="top" align="center" rowspan="1" colspan="1">183</td><td valign="top" align="center" rowspan="1" colspan="1">55.5</td></tr></tbody></table><table-wrap-foot><p>Conv &#x02013; convenience, ELISA &#x02013; enzyme-linked immunosorbent assay. MEIA &#x02013; micro-enzyme immunoassay. RDS &#x02013; respondent-driven sampling</p></table-wrap-foot></table-wrap></sec><sec><title>Quality assessment</title><p>The summarized and study-specific ROB assessments of prevalence measures are in Tables S5 and S6 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>, respectively. Briefly, nearly half of studies (44.7%) used probability-based sampling. Most studies (78.7%) indicated explicitly the biological assay used for STI ascertainment. Response rate information was missing in over half of studies (51.8%).</p><p>Overall, studies were of reasonable quality. Close to 60% of studies had low ROB on at least two quality domains, and none had high ROB on two or more domains.</p></sec><sec><title>Pooled mean prevalence estimates</title><p><xref rid="T4" ref-type="table"><bold>Table 4</bold></xref> shows the results of meta-analyses estimating the pooled mean prevalence of current and/or ever infection for each STI. The mean prevalence of current infection was estimated at 12.7% (95% CI&#x02009;=&#x02009;8.5%-17.7%) for syphilis, 14.4% (95% CI&#x02009;=&#x02009;8.2%-22.0%) for <italic>C. trachomatis</italic>, 5.7% (95% CI&#x02009;=&#x02009;3.5%-8.4%) for <italic>N. gonorrhoeae</italic>, and 7.1% (95% CI&#x02009;=&#x02009;4.3%-10.5%) for <italic>T. vaginalis</italic>.</p><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Results of meta-analyses on prevalence studies for <italic>Treponema pallidum</italic> (syphilis), <italic>Chlamydia trachomatis</italic>, <italic>Neisseria gonorrhoeae</italic>, <italic>Trichomonas vaginalis</italic>, and herpes simplex virus type 2 (HSV-2) among FSWs in the Middle East and North Africa</p></caption><table frame="hsides" rules="groups"><col width="130" span="1"/><col width="40" span="1"/><col width="35" span="1"/><col width="40" span="1"/><col width="44" span="1"/><col width="45" span="1"/><col width="49" span="1"/><col width="45" span="1"/><col width="81" span="1"/><col width="72" span="1"/><col width="62" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Sexually transmitted infection*<hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Studies</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Samples<hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Reported prevalence<hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Pooled mean prevalence<hr/></th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Heterogeneity measures<hr/></th></tr></thead><tbody><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">N&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tested<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Positive<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Median&#x02021; (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Range&#x02021;&#x02028;(%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Estimate (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95% CI<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Q&#x000a7; (<italic>P</italic>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">I2&#x02016; (%; 95% CI)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Prediction interval&#x000b6; (95%)<hr/></td></tr><tr><td colspan="11" valign="top" align="left" scope="col" rowspan="1"><bold>Current infection:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Treponema pallidum</italic> (syphilis)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7103<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">842<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0-62.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.5-17.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1045.3 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96.8 (96.2-97.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-48.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Chlamydia trachomatis</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4608<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">512<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.7-76.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.2-22.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">611.4 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">97.5 (96.9-98.1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-53.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Neisseria gonorrhoeae</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5230<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">301<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0-17.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.5-8.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">248.2 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">92.3 (89.6-94.4)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-21.6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Trichomonas vaginalis</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4258<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">397<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0-19.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.3-10.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">164.7 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">92.7 (89.3-95.0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-23.7<hr/></td></tr><tr><td colspan="11" valign="top" align="left" scope="col" rowspan="1"><bold>Recent infection:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Chlamydia trachomatis</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2**<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">198<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">87<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29.2-95.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td colspan="11" valign="top" align="left" scope="col" rowspan="1"><bold>Ever infection:</bold>&#x02020;&#x02020;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Treponema pallidum</italic> (syphilis)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9968<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">710<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0-92.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.4-16.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1261.0 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96.1 (95.5-96.7)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-45.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Chlamydia trachomatis</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">514<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">395<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">84.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.8-100<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">80.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.2-97.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">213.0 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">97.7 (96.4-98.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-100.0<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Herpes simplex virus type 2 IgG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">942<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.7-59.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.2-40.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">185.0 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96.2 (94.3-97.5)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-84.9<hr/></td></tr><tr><td colspan="11" valign="top" align="left" scope="col" rowspan="1"><bold>Unclear:</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Treponema pallidum</italic> (syphilis)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;698<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">771<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0-29.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.1-10.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">591.3 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">96.4 (95.5-97.2)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0-25.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Chlamydia trachomatis</italic></td><td valign="top" align="center" rowspan="1" colspan="1">2**</td><td valign="top" align="center" rowspan="1" colspan="1">293</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="center" rowspan="1" colspan="1">11.0</td><td valign="top" align="center" rowspan="1" colspan="1">2.9-19.1</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table><table-wrap-foot><p>CI &#x02013; confidence interval, FSWs &#x02013; female sex workers, IgG &#x02013; immunoglobulin G, P &#x02013; <italic>P</italic>-value</p><p>*The same population may have contributed different measures for both current infection and ever (seropositivity using antibody testing) infection.</p><p>&#x02020;Missing sample sizes for measures (or their strata) were imputed using the median sample size calculated from studies with available information (only two stratified measures for <italic>Neisseria gonorrhoeae</italic>, one stratified measure for <italic>Chlamydia trachomatis</italic>, one stratified measure for current syphilis infection, 5 stratified measures of unclear syphilis infection, had their sample size imputed, that is 5% of all data).</p><p>&#x02021;Medians and ranges were calculated based on the stratified prevalence measures.</p><p>&#x000a7;Q &#x02013; the Cochran&#x02019;s Q statistic is a measure assessing the existence of heterogeneity in effect size (here, prevalence) across studies.</p><p>&#x02016;I2 &#x02013; a measure assessing the magnitude of between-study variation that is due to differences in effect size (here, prevalence) across studies rather than chance.</p><p>&#x000b6;Prediction interval: a measure estimating the 95% interval of the distribution of true effect sizes (here, prevalence measures).</p><p>**Meta-analyses were performed if at least three studies were available.</p><p>&#x02020;&#x02020;Ever infection indicates seropositivity using antibody testing.</p></table-wrap-foot></table-wrap><p>The mean prevalence of ever infection was estimated at 12.8% (95% CI&#x02009;=&#x02009;9.4%-16.6%) for syphilis, 80.3% (95% CI&#x02009;=&#x02009;53.2%-97.6%) for <italic>C. trachomatis</italic>, and 23.7% (95% CI&#x02009;=&#x02009;10.2%-40.4%) for HSV-2 IgG.</p><p>There was strong evidence for heterogeneity in effect size (here, prevalence). <italic>P</italic> for Cochran&#x02019;s Q statistic was always &#x0003c;0.0001. I<sup>2</sup> was &#x0003e;90% in all meta-analyses, indicating that most variability is due to true differences in effect size across studies, rather than being due to chance. Prediction intervals were also wide affirming high heterogeneity.</p><p>Additional meta-analyses at the subregional level indicated the mean prevalence of current syphilis infection at 3.0% (95% CI&#x02009;=&#x02009;0.9%-9.2%) in Eastern MENA, 17.6% (95% CI&#x02009;=&#x02009;14.2%-21.3%) in North Africa, and 27.8% (95% CI&#x02009;=&#x02009;15.2%-42.4%) in the Horn of Africa (Table S7 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>). There was also a tendency for a decline in current infection prevalence post-2010 (Table S8 and Figure S1A in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>). For the rest of the STIs, the number of studies was small and the CIs were wide and overlapping to warrant conclusive statement about the temporal trend (Table S8 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>).</p></sec><sec><title>Predictors of variability in syphilis infection</title><p>Country/subregion, year of data collection, diagnostic method, sample size, sampling methodology, and response rate were associated with higher odds of syphilis infection in the univariable meta-regression analyses. These were, therefore, included in the multivariable model (<xref rid="T5" ref-type="table"><bold>Table 5</bold></xref>). About a third of the variability was explained by each of year of data collection and subregion (adjusted R-squared: 34.6% and 31.5%, respectively). Meanwhile, no evidence for an association with infection type (current infection; ever infection), or STI ascertainment (biological assay explicitly indicated; otherwise) was found.</p><table-wrap id="T5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Results of meta-regression analyses to identify associations and sources of between-study heterogeneity in syphilis prevalence in the Middle East and North Africa (MENA)</p></caption><table frame="hsides" rules="groups"><col width="94" span="1"/><col width="103" span="1"/><col width="49" span="1"/><col width="53" span="1"/><col width="71" span="1"/><col width="35" span="1"/><col width="40" span="1"/><col width="44" span="1"/><col width="76" span="1"/><col width="37" span="1"/><col width="38" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Factors<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Studies</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Samples</th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Univariable analyses<hr/></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Multivariable analysis*<hr/></th></tr></thead><tbody><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Total N<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Total n<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">OR&#x02020; (95% CI)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic>&#x02021; of LR test<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Variance explained R2 (%)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AOR&#x02020; (95% CI)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic>&#x000a7; of LR test<hr/></td></tr><tr><td colspan="11" valign="top" align="left" scope="col" rowspan="1"><bold>Country/subregion:&#x02016;</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Eastern MENA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Afghanistan, Iran, Pakistan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10&#x02009;865<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">31.52<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Egypt, Jordan, Yemen<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Egypt, Jordan, Yemen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">881<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.89 (0.15-5.10)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.893<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.66 (0.13-3.28)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.609<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">North Africa<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Algeria, Morocco, Sudan, Tunisia<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;394<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.34 (2.45-11.61)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.01 (2.37-10.61)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Horn of Africa<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Djibouti, Somalia, South Sudan<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5629<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.63 (8.89-52.69)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.40 (2.45-16.69)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Year of data collection</bold>&#x000b6;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">106<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29&#x02009;769<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.85-0.91)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.61<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.93 (0.88-0.98)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.005<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.005<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Infection type</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Current<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7103<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.515<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ever**<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9968<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.25 (0.52-3.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.622<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Unclear<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;698<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.69 (0.23-2.04)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.501<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Diagnostic method</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RPR/VDRL &#x00026; TPHA/FTA-ABS/RDT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">29<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6095<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22.44<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.444<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RPR/VDRL<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">488<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.09 (0.01-0.61)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.013<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76 (0.15-4.00)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.746<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TPHA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1781<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.17 (0.86-5.45)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.099<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.29 (0.54-3.07)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.558<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RDT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8707<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.17 (0.06-0.45)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.46 (0.18-1.18)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.104<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Not specified<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">22<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;698<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.43 (0.16-1.16)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.094<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.75 (0.24-2.33)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.614<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>STI ascertainment</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Biological assay not reported<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13&#x02009;066<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.284<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Biological assay explicitly indicated<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">83<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16&#x02009;703<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.66 (0.65-4.20)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.284<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Sample size</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;100 participants<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1960<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.02&#x02020;&#x02020;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;100 participants<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">64<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27&#x02009;809<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.16 (0.08-0.32)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.60 (0.62-4.15)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.329<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.329<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Sampling methodology</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Non-probability/unclear sampling<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">66<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;555<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.73&#x02021;&#x02021;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Probability-based sampling<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17&#x02009;214<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.16 (0.08-0.34)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.63 (0.25-1.63)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.339<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.339<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Response rate</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;60%/unclear<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">69<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18&#x02009;400<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.23&#x000a7;&#x000a7;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;60%</td><td valign="top" align="center" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">11&#x02009;369</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 (0.12-0.54)</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.73 (0.29-1.84)</td><td valign="top" align="center" rowspan="1" colspan="1">0.495</td><td valign="top" align="center" rowspan="1" colspan="1">0.495</td></tr></tbody></table><table-wrap-foot><p>AOR &#x02013; adjusted odds ratio, CI &#x02013; confidence interval, FTA-ABS &#x02013; fluorescent treponemal antibody absorption test, LR &#x02013; likelihood ratio, OR &#x02013; odds ratio, P &#x02013; <italic>P</italic>-value, RDT &#x02013; rapid diagnostic test, RPR &#x02013; rapid plasma regain, STI &#x02013; sexually transmitted infection TPHA &#x02013; <italic>Treponema pallidum</italic> haemagglutination assay. VDRL &#x02013; venereal disease research laboratory</p><p>*Adjusted R<sup>2</sup> in the multivariable model: 48.46%.</p><p>&#x02020;An increment of 0.1 was added to number of events when generating log odds of syphilis infection. This is because 8 stratified measures had zero events.</p><p>&#x02021;Factors with <italic>P</italic>&#x02009;&#x02264;&#x02009;0.1 were eligible for inclusion in the multivariable analysis.</p><p>&#x000a7;Factors with <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 in the multivariable model were considered as significant predictors.</p><p>&#x02016;Countries were grouped based on geography and similarity in prevalence levels.</p><p>&#x000b6;Missing values for year of data collection (only one stratified measure) were imputed using data for year of publication adjusted by the median difference between year of publication and median year of data collection for studies with complete information.</p><p>**Ever infection indicates seropositivity using antibody testing.</p><p>&#x02020;&#x02020;The high R<sup>2</sup> was investigated and found to be due to confounding with year of data collection. Most studies with sample size &#x02265;100 were conducted in recent years.</p><p>&#x02021;&#x02021;The high R<sup>2</sup> was investigated and found to be due to confounding with country and year of data collection. Studies with non-probability sampling were mostly from the Horn of Africa. These studies tended also to be conducted in earlier years.</p><p>&#x000a7;&#x000a7;The high R<sup>2</sup> was investigated and found to be due to confounding with year of data collection. Most studies with response rate &#x02265;60% were conducted in recent years.</p></table-wrap-foot></table-wrap><p>The multivariable analysis showed strong evidence for subregional differences, with Horn of Africa and North Africa showing, respectively, 6-fold (adjusted odds ratio (AOR): 6.4; 95% CI&#x02009;=&#x02009;2.5-16.7) and 5-fold (AOR&#x02009;=&#x02009;5.0; 95% CI&#x02009;=&#x02009;2.5-10.6), higher odds of syphilis infection than Eastern MENA.</p><p>There was also strong evidence for a temporal trend of decreasing odds of infection at 7% per year (AOR&#x02009;=&#x02009;0.93; 95% CI&#x02009;=&#x02009;0.88-0.98; linearity dictated by data (Figure S1 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>) over the last three decades. Although this trend was noted in all subregions, individual subregion meta-regressions were not always powered to detect statistical significance (not shown).</p><p>No evidence for an association with diagnostic method, sample size, sampling methodology, and response rate was identified in the multivariable model. The multivariable model explained 48.5% of variation in syphilis prevalence.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>We provided, to our knowledge, the first detailed assessment of the epidemiology of key STIs in FSWs in MENA, a neglected key population. Our findings indicated substantial STI prevalence, several folds higher than that among the general population [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R86" ref-type="bibr">86</xref>]. These findings suggest a major role for CHSNs in driving STI transmission in MENA. We further found large heterogeneity in syphilis infection levels by subregion within MENA, as well as a trend of decreasing odds of infection by&#x02009;~&#x02009;7% per year &#x02013; less than the 17% [<xref rid="R86" ref-type="bibr">86</xref>] annual decline needed to achieve the target of 90% reduction in syphilis incidence by 2030 [<xref rid="R6" ref-type="bibr">6</xref>].</p><p>Despite the significant infection burden, STI surveillance and response in MENA continue to be rudimentary [<xref rid="R21" ref-type="bibr">21</xref>], and far below the coverage targets of WHO Global Health Sector Strategy for STIs [<xref rid="R6" ref-type="bibr">6</xref>]. Infected individuals are often identified through routine case notifications with surveillance/testing being largely limited to HIV [<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R87" ref-type="bibr">87</xref>], and sexual health programs, where they exist, cater to general population women rather than women at high risk [<xref rid="R24" ref-type="bibr">24</xref>].</p><p>Although our expansive search identified considerable evidence at the regional-level, including data that will appear in the scientific literature for the first time, evidence varied by country. Over half of countries had no data on any of the STIs in this key population, less than a third had data on <italic>C. trachomatis</italic>, <italic>N. gonorrhoeae</italic>, or <italic>T. vaginalis</italic>, and only three countries had data on HSV-2 IgG (<xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>, <xref rid="T2" ref-type="table"><bold>Table 2</bold></xref> and <xref rid="T3" ref-type="table"><bold>Table 3</bold></xref>). This outcome is of concern, given the considerable, yet preventable, STI infection burden among FSWs in the region (<xref rid="T4" ref-type="table"><bold>Table 4</bold></xref>), and the major &#x0201c;core group&#x0201d; role that CHSNs play in STI transmission in any population [<xref rid="R10" ref-type="bibr">10</xref>]. Indeed, while the population proportion of FSWs (proportion of FSWs out of the total women population) varies across countries and may seem relatively small [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R88" ref-type="bibr">88</xref>], the size of CHSNs is large suggesting a considerable number of women and men at risk of STI-related morbidity, either through engagement in high sexual risk behavior, or through onward infection transmission [<xref rid="R89" ref-type="bibr">89</xref>].</p><p>Availability of STI data stands in contrast to HIV data, for which the volume of evidence among FSWs was several fold higher and encompassed most countries [<xref rid="R18" ref-type="bibr">18</xref>]. Attending to WHO Global Health Sector Strategy on STIs [<xref rid="R6" ref-type="bibr">6</xref>] necessitates a major expansion of STI research and surveillance, as has been done for HIV [<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R87" ref-type="bibr">87</xref>,<xref rid="R90" ref-type="bibr">90</xref>]. Regrettably, integrated bio-behavioural surveillance surveys (IBBSS) among key populations continue to be focused on HIV, rarely incorporating STIs [<xref rid="R91" ref-type="bibr">91</xref>,<xref rid="R92" ref-type="bibr">92</xref>]. This presents an important, yet lost, opportunity for monitoring STI levels and trends in key populations, informing programming efforts, gaining an in-depth understanding of sexual networks&#x02019; structure, and advancing STI research in this region [<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R91" ref-type="bibr">91</xref>,<xref rid="R93" ref-type="bibr">93</xref>].</p><p>Subregion and time explained most variation in syphilis prevalence&#x02014;each explained over a third of the variation, and both (remarkably) explained&#x02009;~&#x02009;50% of the variation (<xref rid="T5" ref-type="table"><bold>Table 5</bold></xref>). The strong subregional differences, with Horn of Africa showing the highest prevalence, followed by North Africa, and then Eastern MENA <bold>(</bold><xref rid="T5" ref-type="table"><bold>Table 5</bold></xref> and Table S7 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>), appear to reflect variability in the risk environment, such as differences in structure of sexual networks [<xref rid="R24" ref-type="bibr">24</xref>], condom use [<xref rid="R18" ref-type="bibr">18</xref>], and access to care [<xref rid="R24" ref-type="bibr">24</xref>]. The same pattern has been seen in HIV epidemiology among FSWs [<xref rid="R18" ref-type="bibr">18</xref>].</p><p>There was strong evidence for a time trend of decreasing odds of infection at&#x02009;~&#x02009;7% per year (<xref rid="T5" ref-type="table"><bold>Table 5</bold></xref>, and Table S8 and Figure S1 in the OSD), consistent with, but smaller than, the decline reported for the general population in MENA in a recent global analysis [<xref rid="R86" ref-type="bibr">86</xref>], and the declines reported for the general populations in other regions [<xref rid="R86" ref-type="bibr">86</xref>]. Different factors may have contributed to this trend including safer sex following the HIV epidemic [<xref rid="R94" ref-type="bibr">94</xref>], increased condom use to prevent unwanted pregnancy [<xref rid="R18" ref-type="bibr">18</xref>], and HIV-related mortality which may have disproportionally affected populations at higher risk of STIs [<xref rid="R95" ref-type="bibr">95</xref>]. This may have been also a consequence of a shorter duration of active syphilis infection in FSWs or their sex partners [<xref rid="R96" ref-type="bibr">96</xref>,<xref rid="R97" ref-type="bibr">97</xref>], possibly because of improvements in syphilis diagnostics and treatment, or because of widespread use of antibiotics (including for non-STI infections, which sometimes may cure concurrent syphilis) [<xref rid="R86" ref-type="bibr">86</xref>].</p><p>This being said, recent surveillance data seems also to suggest an increase in syphilis incidence and/or prevalence in other sexual networks or in specific settings, such as among MSM [<xref rid="R98" ref-type="bibr">98</xref>-<xref rid="R100" ref-type="bibr">100</xref>], and even among reproductive-age women in few countries where congenital syphilis appears to be rising [<xref rid="R101" ref-type="bibr">101</xref>,<xref rid="R102" ref-type="bibr">102</xref>]. Contributors to these trends may include behavioral factors, such as more sexual partners and unprotected sex among MSM, as well as contextual factors, and possibly even biological factors [<xref rid="R99" ref-type="bibr">99</xref>,<xref rid="R100" ref-type="bibr">100</xref>,<xref rid="R102" ref-type="bibr">102</xref>-<xref rid="R104" ref-type="bibr">104</xref>].</p><p>Prevalence measures for syphilis and for <italic>C. trachomatis</italic> in FSWs in MENA were comparable to global levels [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>], but prevalence measures for <italic>N. gonorrhoeae</italic> and <italic>T. vaginalis</italic> leaned towards the lower end of the global range [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]. Even though the risk environment among FSWs in MENA seems less conducive to STI transmission, as compared to other regions [<xref rid="R18" ref-type="bibr">18</xref>], STI prevalence levels are substantial, perhaps affected by poor access to health care and prevention interventions [<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R105" ref-type="bibr">105</xref>], as well as absence of enabling environments for this vulnerable population, in a context of criminality [<xref rid="R106" ref-type="bibr">106</xref>,<xref rid="R107" ref-type="bibr">107</xref>] and stigma [<xref rid="R108" ref-type="bibr">108</xref>-<xref rid="R110" ref-type="bibr">110</xref>].</p><p>While interventions aiming at promoting safer sex, such as condom use, and STI etiological diagnosis and treatment, in high risk populations are widely accepted and advocated for [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R111" ref-type="bibr">111</xref>-<xref rid="R114" ref-type="bibr">114</xref>], STI syndromic case management and presumptive treatment have been increasingly subject to criticism amid growing concerns about their role in promoting pathogens&#x02019; antimicrobial resistance (AMR) [<xref rid="R111" ref-type="bibr">111</xref>,<xref rid="R115" ref-type="bibr">115</xref>-<xref rid="R119" ref-type="bibr">119</xref>]. Indeed, substantial AMR prevalence and multiple drug resistant strains have been found in gonococcal isolates from FSWs in sub-Saharan Africa [<xref rid="R120" ref-type="bibr">120</xref>,<xref rid="R121" ref-type="bibr">121</xref>] and elsewhere [<xref rid="R122" ref-type="bibr">122</xref>]. This suggests that despite the effectiveness of targeted STI treatment services in reducing STI incidence and prevalence, their appropriateness and sustainable implementation will need to be informed by surveillance and monitoring, notably for AMR, and thus may vary across settings [<xref rid="R111" ref-type="bibr">111</xref>,<xref rid="R122" ref-type="bibr">122</xref>]. This further supports WHO efforts towards building a global business case for accelerating development of STI vaccines as a fundamental solution to STI drug resistance [<xref rid="R123" ref-type="bibr">123</xref>-<xref rid="R125" ref-type="bibr">125</xref>].</p><p>This study is limited by the quantity and quality of available data. STI prevalence among FSWs remains unknown in over half of countries. While there was considerable evidence for syphilis, less evidence was found for <italic>C. trachomatis</italic>, <italic>N. gonorrhoeae</italic>, <italic>T. vaginalis</italic>, and HSV-2, limiting our ability to conduct advanced meta-analytics&#x02014;meta-regressions were carried out only for syphilis. Though, for syphilis prevalence, the differences between current vs ever (seropositivity using antibody testing) infection, as well as the differences between diagnostics, were consistent with the findings of a large global analysis for the general population [<xref rid="R86" ref-type="bibr">86</xref>], the confidence intervals were wide owing to the smaller number of studies (<xref rid="T5" ref-type="table"><bold>Table 5</bold></xref>). Several measures were based on routine data reporting, and did not include sufficient documentation of study methodology. There was also a wide array of diagnostics used for STI ascertainment, which may have affected observed prevalence.</p><p>Available studies may not be representative of the wider population of FSWs, or could be subject to biases, such as selection bias or detection bias. Of note, however, that there was no evidence that any of the assessed study-specific quality domains (Tables S5-S6 in <xref ref-type="supplementary-material" rid="S1"><bold>Online Supplementary Document</bold></xref>), including sampling methodology, response rate, and explicit indication of the assay used for infection ascertainment, had an effect on prevalence in the multivariable meta-regression (<xref rid="T5" ref-type="table"><bold>Table 5</bold></xref>). Despite limitations, our study provided a detailed synthesis of STI epidemiology in FSWs in MENA, in a background of lack of evidence for this region [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]. A significant volume of published and unpublished data was identified and analyzed, and for the first time.</p><p>In conclusion, STI levels among FSWs are considerable, supporting a key role for CHSNs in STI transmission dynamics in MENA, and highlighting the public health needs of this neglected and vulnerable population. Despite the progress in our epidemiological understanding, major gaps persist, with no evidence being available for over half of MENA countries. With the limited STI surveillance [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R126" ref-type="bibr">126</xref>], and the focus of programmatic response on case management and syndromic approach, rather than being evidence-informed and grounded on etiological studies [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R126" ref-type="bibr">126</xref>], there is a critical need to expand STI surveillance and the broader STI research agenda. STI testing should be part of IBBSS studies, as well as part of voluntary counseling and testing services for HIV [<xref rid="R91" ref-type="bibr">91</xref>,<xref rid="R93" ref-type="bibr">93</xref>]. Interventions should factor research findings to ensure adequate and efficient resource allocation. Without such expansion of STI efforts, it will not be possible to monitor infection trends, or to inform a public health response that attends to the WHO Global Health Sector Strategy on STIs [<xref rid="R6" ref-type="bibr">6</xref>].</p></sec><sec sec-type="supplementary-material"><title>Additional material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Online Supplementary Document</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="jogh-09-020408-s001.pdf" orientation="portrait" id="d35e7059" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors gratefully acknowledge Professor Rhoda Ashley-Morrow from the University of Washington, for her support in assessing the quality of herpes simplex virus type 2 diagnostic methods. The authors also gratefully acknowledge Ms. May Al-Kassar for her assistance with study diagnostics, and Ms. Adona Canlas for her assistance with locating full-texts of articles. The authors further gratefully acknowledge the Department of Reproductive Health and Research at the World Health Organization, for making syphilis routine data reporting available for public use, through the Global Health Observatory data repository. Ethics approval deemed as not required for this research by the Research Governance &#x00026; Integrity Office at the London School of Hygiene and Tropical Medicine.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This publication was made possible by NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). Infrastructure support was provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medicine-Qatar. Salary for HAW was from the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (K012126/1). The statements made herein are solely the responsibility of the authors.</p></fn><fn fn-type="other"><p><bold>Authorship contributions:</bold> HC conceived and designed the study, conducted the systematic review of the literature, performed the data analyses, and wrote the first draft of the article. AS double extracted the data. EM contributed to the title and abstract screening of regional and country-level databases. HAW contributed to study design, data analyses, and drafting of the article. LJA contributed to study design, data analyses, and drafting of the article. All authors contributed to discussion and interpretation of the results and writing of the manuscript. All authors have read and approved the final manuscript.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> The authors have completed the Unified Competing Interest form at <ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/coi_disclosure.pdf">www.icmje.org/coi_disclosure.pdf</ext-link> (available on request from the corresponding author) and declare no competing interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><mixed-citation publication-type="book">World Health Organization. Report on globally sexually transmitted infection surveillance 2015. Geneva, Switzerland: World Health Organization, 2016.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>L</given-names></name><name><surname>Rowley</surname><given-names>J</given-names></name><name><surname>Vander Hoorn</surname><given-names>S</given-names></name><name><surname>Wijesooriya</surname><given-names>NS</given-names></name><name><surname>Unemo</surname><given-names>M</given-names></name><name><surname>Low</surname><given-names>N</given-names></name><etal/></person-group><article-title>Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting.</article-title>
<source>PLoS One</source>. <year>2015</year>;<volume>10</volume>:<elocation-id>e0143304</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0143304</pub-id><?supplied-pmid 26646541?><pub-id pub-id-type="pmid">26646541</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Looker</surname><given-names>KJ</given-names></name><name><surname>Magaret</surname><given-names>AS</given-names></name><name><surname>Turner</surname><given-names>KM</given-names></name><name><surname>Vickerman</surname><given-names>P</given-names></name><name><surname>Gottlieb</surname><given-names>SL</given-names></name><name><surname>Newman</surname><given-names>LM</given-names></name></person-group><article-title>Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.</article-title>
<source>PLoS One</source>. <year>2015</year>;<volume>10</volume>:<elocation-id>e114989</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0114989</pub-id><?supplied-pmid 25608026?><pub-id pub-id-type="pmid">25608026</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>LF</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group><article-title>The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis.</article-title>
<source>Sex Transm Dis</source>. <year>2008</year>;<volume>35</volume>:<fpage>946</fpage>-<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1097/OLQ.0b013e3181812d15</pub-id><?supplied-pmid 18685546?><pub-id pub-id-type="pmid">18685546</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MS</given-names></name></person-group><article-title>Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis.</article-title>
<source>Lancet</source>. <year>1998</year>;<volume>351</volume>
<issue>Suppl 3</issue>:<fpage>5</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(98)90002-2</pub-id><?supplied-pmid 9652712?><pub-id pub-id-type="pmid">9652712</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="other">World Health Organization. Global health sector strategy on sexually transmitted infections, 2016-2021. Geneva, Switzerland: World Health Organization, 2016 Contract No.: WHO/RHR/16.09.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="book">World Bank, Centers for Disease Prevention and Control. Sexually transmitted infections in developing countries. 2009. Accessed.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JC</given-names></name><name><surname>Tucker</surname><given-names>MJ</given-names></name></person-group><article-title>The development and use of the concept of a sexually transmitted disease core.</article-title>
<source>J Infect Dis</source>. <year>1996</year>;<volume>174</volume>
<issue>Suppl 2</issue>:<fpage>S134</fpage>-<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/174.Supplement_2.S134</pub-id><?supplied-pmid 8843243?><pub-id pub-id-type="pmid">8843243</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilmarx</surname><given-names>PH</given-names></name></person-group><article-title>Global epidemiology of HIV.</article-title>
<source>Curr Opin HIV AIDS</source>. <year>2009</year>;<volume>4</volume>:<fpage>240</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/COH.0b013e32832c06db</pub-id><?supplied-pmid 19532059?><pub-id pub-id-type="pmid">19532059</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunham</surname><given-names>RC</given-names></name><name><surname>Plummer</surname><given-names>FA</given-names></name></person-group><article-title>A general model of sexually transmitted disease epidemiology and its implications for control.</article-title>
<source>Med Clin North Am</source>. <year>1990</year>;<volume>74</volume>:<fpage>1339</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0025-7125(16)30484-9</pub-id><?supplied-pmid 2246943?><pub-id pub-id-type="pmid">2246943</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname><given-names>R</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>Sexual network drivers of HIV and herpes simplex virus type 2 transmission.</article-title>
<source>AIDS</source>. <year>2017</year>;<volume>31</volume>:<fpage>1721</fpage>-<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000001542</pub-id><?supplied-pmid 28514276?><pub-id pub-id-type="pmid">28514276</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouyoumjian</surname><given-names>SP</given-names></name><name><surname>Heijnen</surname><given-names>M</given-names></name><name><surname>Chaabna</surname><given-names>K</given-names></name><name><surname>Mumtaz</surname><given-names>GR</given-names></name><name><surname>Omori</surname><given-names>R</given-names></name><name><surname>Vickerman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.</article-title>
<source>AIDS</source>. <year>2018</year>;<volume>32</volume>:<fpage>1343</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000001828</pub-id><?supplied-pmid 29794495?><pub-id pub-id-type="pmid">29794495</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name><surname>Schiffer</surname><given-names>JT</given-names></name><name><surname>Ashley</surname><given-names>R</given-names></name><name><surname>Mumtaz</surname><given-names>G</given-names></name><name><surname>Alsallaq</surname><given-names>RA</given-names></name><name><surname>Akala</surname><given-names>FA</given-names></name><etal/></person-group><article-title>HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.</article-title>
<source>Epidemics</source>. <year>2010</year>;<volume>2</volume>:<fpage>173</fpage>-<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2010.08.003</pub-id><?supplied-pmid 21352788?><pub-id pub-id-type="pmid">21352788</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname><given-names>R</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>Population sexual behavior and HIV prevalence in sub-Saharan Africa: Missing links?</article-title>
<source>IJID</source>. <year>2016</year>;<volume>44</volume>:<fpage>1</fpage>-<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2016.01.005</pub-id><?supplied-pmid 26780269?><pub-id pub-id-type="pmid">26780269</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>RM</given-names></name><name><surname>Renzetti</surname><given-names>CM</given-names></name></person-group><article-title>The problems of researching sensitive topics.</article-title>
<source>Am Behav Sci</source>. <year>1990</year>;<volume>33</volume>:<fpage>510</fpage>-<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1177/0002764290033005002</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="other">United Nations. Transforming our world: The 2030 agenda for sustainable development. 2015 A/RES/70/1.</mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saba</surname><given-names>HF</given-names></name><name><surname>Kouyoumjian</surname><given-names>SP</given-names></name><name><surname>Mumtaz</surname><given-names>GR</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>Characterising the progress in HIV/AIDS research in the Middle East and North Africa.</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>
<issue>Suppl 3</issue>:<fpage>iii5</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2012-050888</pub-id><?supplied-pmid 23596206?><pub-id pub-id-type="pmid">23596206</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chemaitelly</surname><given-names>H</given-names></name><name><surname>Weiss</surname><given-names>HA</given-names></name><name><surname>Thomas</surname><given-names>SL</given-names></name><name><surname>Calvert</surname><given-names>C</given-names></name><name><surname>Harfouche</surname><given-names>M</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>HIV epidemiology among female sex workers and their clients in the Middle East and North Africa: Systematic review, meta-analyses, and meta-regressions.</article-title>
<source>BMC Med</source>. <year>2019</year>;<volume>17</volume>:<fpage>119</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-019-1349-y</pub-id><?supplied-pmid 31230594?><pub-id pub-id-type="pmid">31230594</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumtaz</surname><given-names>GR</given-names></name><name><surname>Weiss</surname><given-names>HA</given-names></name><name><surname>Thomas</surname><given-names>SL</given-names></name><name><surname>Riome</surname><given-names>S</given-names></name><name><surname>Setayesh</surname><given-names>H</given-names></name><name><surname>Riedner</surname><given-names>G</given-names></name><etal/></person-group><article-title>HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis.</article-title>
<source>PLoS Med</source>. <year>2014</year>;<volume>11</volume>:<elocation-id>e1001663</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1001663</pub-id><?supplied-pmid 24937136?><pub-id pub-id-type="pmid">24937136</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumtaz</surname><given-names>G</given-names></name><name><surname>Hilmi</surname><given-names>N</given-names></name><name><surname>McFarland</surname><given-names>W</given-names></name><name><surname>Kaplan</surname><given-names>RL</given-names></name><name><surname>Akala</surname><given-names>FA</given-names></name><name><surname>Semini</surname><given-names>I</given-names></name><etal/></person-group><article-title>Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: A systematic review and data synthesis.</article-title>
<source>PLoS Med</source>. <year>2010</year>;<volume>8</volume>: <elocation-id>e1000444</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000444</pub-id><?supplied-pmid 21829329?><pub-id pub-id-type="pmid">21829329</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name><surname>Ghanem</surname><given-names>KG</given-names></name><name><surname>Feizzadeh</surname><given-names>A</given-names></name><name><surname>Setayesh</surname><given-names>H</given-names></name><name><surname>Calleja</surname><given-names>JM</given-names></name><name><surname>Riedner</surname><given-names>G</given-names></name></person-group><article-title>HIV and other sexually transmitted infection research in the Middle East and North Africa: Promising progress?</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>
<issue>Suppl 3</issue>:<fpage>iii1</fpage>-<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2013-051373</pub-id><?supplied-pmid 24191291?><pub-id pub-id-type="pmid">24191291</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cwikel</surname><given-names>JG</given-names></name><name><surname>Lazer</surname><given-names>T</given-names></name><name><surname>Press</surname><given-names>F</given-names></name><name><surname>Lazer</surname><given-names>S</given-names></name></person-group><article-title>Sexually transmissible infections among female sex workers: An international review with an emphasis on hard-to-access populations.</article-title>
<source>Sex Health</source>. <year>2008</year>;<volume>5</volume>:<fpage>9</fpage>-<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1071/SH07024</pub-id><?supplied-pmid 18361849?><pub-id pub-id-type="pmid">18361849</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname><given-names>L</given-names></name><name><surname>Grenfell</surname><given-names>P</given-names></name><name><surname>Fletcher</surname><given-names>A</given-names></name><name><surname>Sorhaindo</surname><given-names>A</given-names></name><name><surname>Jolley</surname><given-names>E</given-names></name><name><surname>Rhodes</surname><given-names>T</given-names></name><etal/></person-group><article-title>Systematic review examining differences in HIV, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers.</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>:<fpage>311</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2012-050491</pub-id><?supplied-pmid 23112339?><pub-id pub-id-type="pmid">23112339</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="book">Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for strategic action. World Bank/UNAIDS/WHO Publication, editor. Washington DC: The World Bank Press; 2010.</mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name><surname>Hilmi</surname><given-names>N</given-names></name><name><surname>Mumtaz</surname><given-names>G</given-names></name><name><surname>Benkirane</surname><given-names>M</given-names></name><name><surname>Akala</surname><given-names>FA</given-names></name><name><surname>Riedner</surname><given-names>G</given-names></name><etal/></person-group><article-title>Epidemiology of HIV infection in the Middle East and North Africa.</article-title>
<source>AIDS</source>. <year>2010</year>;<volume>24</volume>:<fpage>S5</fpage>-<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1097/01.aids.0000386729.56683.33</pub-id><?supplied-pmid 20610949?><pub-id pub-id-type="pmid">20610949</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="book">Higgins JPT, Green S. Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester, England; Hoboken, NJ: Wiley-Blackwell; 2015.</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Group</surname><given-names>P</given-names></name></person-group><article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.</article-title>
<source>PLoS Med</source>. <year>2009</year>;<volume>6</volume>:<elocation-id>e1000097</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><?supplied-pmid 19621072?><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="web">World Health Organization. Global health observatory data repository. 2018. Available: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gho/data/node.main.A1360STI?lang=en">http://apps.who.int/gho/data/node.main.A1360STI?lang=en</ext-link>. Accessed.</mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="web">International AIDS Society. Abstract archives of International AIDS Society conferences. Found at: http://wwwabstract-archiveorg/. Last accessed on 28th of July 2018.</mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="book">Higgins JPT, Green S. Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester, England; Hoboken, NJ: Wiley-Blackwell; 2008.</mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>RL</given-names></name><name><surname>Militoni</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>F</given-names></name><name><surname>Nahmias</surname><given-names>A</given-names></name><name><surname>Corey</surname><given-names>L</given-names></name></person-group><article-title>Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.</article-title>
<source>J Clin Microbiol</source>. <year>1988</year>;<volume>26</volume>:<fpage>662</fpage>-<lpage>7</lpage>.<?supplied-pmid 2835389?><pub-id pub-id-type="pmid">2835389</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>RL</given-names></name></person-group><article-title>Performance and use of HSV type-specific serology test kits.</article-title>
<source>Herpes</source>. <year>2002</year>;<volume>9</volume>:<fpage>38</fpage>-<lpage>45</lpage>.<?supplied-pmid 12106510?><pub-id pub-id-type="pmid">12106510</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MF</given-names></name><name><surname>Tukey</surname><given-names>JW</given-names></name></person-group><article-title>Transformations related to the angular and the square root.</article-title>
<source>Ann Math Stat</source>. <year>1950</year>;<volume>21</volume>:<fpage>607</fpage>-<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1214/aoms/1177729756</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JJ</given-names></name></person-group><article-title>The inverse of the Freeman &#x02013; Tukey double arcsine transformation.</article-title>
<source>Am Stat</source>. <year>1978</year>;<volume>32</volume>:<fpage>138</fpage>.</mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barendregt</surname><given-names>JJ</given-names></name><name><surname>Doi</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>YY</given-names></name><name><surname>Norman</surname><given-names>RE</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name></person-group><article-title>Meta-analysis of prevalence.</article-title>
<source>J Epidemiol Community Health</source>. <year>2013</year>;<volume>67</volume>:<fpage>974</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/jech-2013-203104</pub-id><?supplied-pmid 23963506?><pub-id pub-id-type="pmid">23963506</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Laird</surname><given-names>N</given-names></name></person-group><article-title>Meta-analysis in clinical trials.</article-title>
<source>Control Clin Trials</source>. <year>1986</year>;<volume>7</volume>:<fpage>177</fpage>-<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0197-2456(86)90046-2</pub-id><?supplied-pmid 3802833?><pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="book">Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley &#x00026; Sons; 2009.</mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name></person-group><article-title>Quantifying heterogeneity in a meta-analysis.</article-title>
<source>Stat Med</source>. <year>2002</year>;<volume>21</volume>:<fpage>1539</fpage>-<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/sim.1186</pub-id><?supplied-pmid 12111919?><pub-id pub-id-type="pmid">12111919</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="book">R core team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.</mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="book">StataCorp. Stata statistical software: Release 15.1. College Station, TX: StataCorp LP; 2017.</mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazerooni</surname><given-names>PA</given-names></name><name><surname>Motazedian</surname><given-names>N</given-names></name><name><surname>Motamedifar</surname><given-names>M</given-names></name><name><surname>Sayadi</surname><given-names>M</given-names></name><name><surname>Sabet</surname><given-names>M</given-names></name><name><surname>Lari</surname><given-names>MA</given-names></name><etal/></person-group><article-title>The prevalence of human immunodeficiency virus and sexually transmitted infections among female sex workers in Shiraz, south of Iran: By respondent-driven sampling.</article-title>
<source>Int J STD AIDS</source>. <year>2014</year>;<volume>25</volume>:<fpage>155</fpage>-<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1177/0956462413496227</pub-id><?supplied-pmid 23970644?><pub-id pub-id-type="pmid">23970644</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navadeh</surname><given-names>S</given-names></name><name><surname>Mirzazadeh</surname><given-names>A</given-names></name><name><surname>Mousavi</surname><given-names>L</given-names></name><name><surname>Haghdoost</surname><given-names>A</given-names></name><name><surname>Fahimfar</surname><given-names>N</given-names></name><name><surname>Sedaghat</surname><given-names>A</given-names></name></person-group><article-title>HIV, HSV2 and syphilis prevalence in female sex workers in Kerman, South-East Iran; using respondent-driven sampling.</article-title>
<source>Iran J Public Health</source>. <year>2012</year>;<volume>41</volume>:<fpage>60</fpage>-<lpage>5</lpage>.<?supplied-pmid 23641392?><pub-id pub-id-type="pmid">23641392</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>HJ</given-names></name><name><surname>Omar</surname><given-names>K</given-names></name><name><surname>Adan</surname><given-names>SY</given-names></name><name><surname>Guled</surname><given-names>AM</given-names></name><name><surname>Grillner</surname><given-names>L</given-names></name><name><surname>Bygdeman</surname><given-names>S</given-names></name></person-group><article-title>Syphilis and human immunodeficiency virus seroconversion during a 6-month follow-up of female prostitutes in Mogadishu, Somalia.</article-title>
<source>Int J STD AIDS</source>. <year>1991</year>;<volume>2</volume>:<fpage>119</fpage>-<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1177/095646249100200209</pub-id><?supplied-pmid 2043703?><pub-id pub-id-type="pmid">2043703</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>CS</given-names></name><name><surname>Nasir</surname><given-names>A</given-names></name><name><surname>Stanekzai</surname><given-names>MR</given-names></name><name><surname>Bautista</surname><given-names>CT</given-names></name><name><surname>Botros</surname><given-names>BA</given-names></name><name><surname>Scott</surname><given-names>PT</given-names></name><etal/></person-group><article-title>HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities.</article-title>
<source>AIDS</source>. <year>2010</year>;<volume>24</volume>
<issue>Suppl 2</issue>:<fpage>S69</fpage>-<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1097/01.aids.0000386736.25296.8d</pub-id><?supplied-pmid 20610952?><pub-id pub-id-type="pmid">20610952</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="book">Ministry of Health and Population, National AIDS Program. Evaluation of selected reproductive health infections in various Egyptian population groups in Greater Cairo. Cairo, Egypt: 2000.</mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassaian</surname><given-names>N</given-names></name><name><surname>Ataei</surname><given-names>B</given-names></name><name><surname>Yaran</surname><given-names>M</given-names></name><name><surname>Babak</surname><given-names>A</given-names></name><name><surname>Shoaei</surname><given-names>P</given-names></name><name><surname>Ataie</surname><given-names>M</given-names></name></person-group><article-title>HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran.</article-title>
<source>Adv Biomed Res</source>. <year>2012</year>;<volume>1</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.4103/2277-9175.94427</pub-id><?supplied-pmid 23210064?><pub-id pub-id-type="pmid">23210064</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahanbakhsh</surname><given-names>F</given-names></name><name><surname>Bagheri Amiri</surname><given-names>F</given-names></name><name><surname>Sedaghat</surname><given-names>A</given-names></name><name><surname>Fahimfar</surname><given-names>N</given-names></name><name><surname>Mostafavi</surname><given-names>E</given-names></name></person-group><article-title>Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and syphilis among sheltered homeless adults in Tehran, 2012.</article-title>
<source>Int J Health Policy Manag</source>. <year>2017</year>;<volume>7</volume>:<fpage>225</fpage>-<lpage>30</lpage>. <pub-id pub-id-type="doi">10.15171/ijhpm.2017.74</pub-id><?supplied-pmid 29524951?><pub-id pub-id-type="pmid">29524951</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="other">Royaume du Maroc-Ministere de la Sante. Etude de prevalence des IST chez les femmes qui consultent pour pertes vaginales et/ou douleurs du bas ventre. Rabat, Maroc: Programme National de lutte contre les IST/SIDA, 2008.</mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="book">Ministry of Health-Morocco, The Joint United Nations Programme on HIV/AIDS (UNAIDS), The Global Fund. HIV integrated behavioral and biological surveillance surveys-Morocco 2011: Female sex workers in Agadir, Fes, Rabat and Tanger. Morocco: 2012.</mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baqi</surname><given-names>S</given-names></name><name><surname>Nabi</surname><given-names>N</given-names></name><name><surname>Hasan</surname><given-names>SN</given-names></name><name><surname>Khan</surname><given-names>AJ</given-names></name><name><surname>Pasha</surname><given-names>O</given-names></name><name><surname>Kayani</surname><given-names>N</given-names></name><etal/></person-group><article-title>HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan.</article-title>
<source>J Acquir Immune Defic Syndr Hum Retrovirol</source>. <year>1998</year>;<volume>18</volume>:<fpage>73</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/00042560-199805010-00011</pub-id><?supplied-pmid 9593461?><pub-id pub-id-type="pmid">9593461</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehan</surname><given-names>N</given-names></name><name><surname>Bokhari</surname><given-names>A</given-names></name><name><surname>Nizamani</surname><given-names>NM</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Naqvi</surname><given-names>HR</given-names></name><name><surname>Qayyum</surname><given-names>K</given-names></name><etal/></person-group><article-title>National study of reproductive tract infections among high risk groups of Lahore and Karachi.</article-title>
<source>J Coll Physicians Surg Pak.</source>
<year>2009</year>;<volume>19</volume>:<fpage>228</fpage>-<lpage>31</lpage>.<?supplied-pmid 19356337?><pub-id pub-id-type="pmid">19356337</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="book">Ministry of Health-Pakistan National AIDS Control Program. National study of reproductive tract and sexually transmitted infections: A survey of high risk groups in Lahore and Karachi, Pakistan. 2005.</mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="confproc">Shah AS, Memon MA, Soomro S, Kazi N, Kristensen S, editors. Seroprevelance of HIV, syphilis, hepatitis B and hepatitis C among female commercial sex workers in Hyderabad, Pakistan. International AIDS Conference, C12368; 2004.</mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>S</given-names></name><name><surname>Collumbien</surname><given-names>M</given-names></name><name><surname>Platt</surname><given-names>L</given-names></name><name><surname>Lalji</surname><given-names>N</given-names></name><name><surname>Rizvi</surname><given-names>N</given-names></name><name><surname>Andreasen</surname><given-names>A</given-names></name><etal/></person-group><article-title>HIV and other sexually transmitted infections among men, transgenders and women selling sex in two cities in Pakistan: A cross-sectional prevalence survey.</article-title>
<source>Sex Transm Infect</source>. <year>2009</year>;<volume>85</volume>:<fpage>ii8</fpage>-<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1136/sti.2008.033910</pub-id><?supplied-pmid 19307351?><pub-id pub-id-type="pmid">19307351</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MS</given-names></name><name><surname>Unemo</surname><given-names>M</given-names></name><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>Lundborg</surname><given-names>CS</given-names></name></person-group><article-title>HIV, STI prevalence and risk behaviours among women selling sex in Lahore, Pakistan.</article-title>
<source>BMC Infect Dis</source>. <year>2011</year>;<volume>11</volume>:<fpage>119</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-11-119</pub-id><?supplied-pmid 21569319?><pub-id pub-id-type="pmid">21569319</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jama</surname><given-names>H</given-names></name><name><surname>Hederstedt</surname><given-names>B</given-names></name><name><surname>Osman</surname><given-names>S</given-names></name><name><surname>Omar</surname><given-names>K</given-names></name><name><surname>Isse</surname><given-names>A</given-names></name><name><surname>Bygdeman</surname><given-names>S</given-names></name></person-group><article-title>Syphilis in women of reproductive age in Mogadishu, Somalia: Serological survey.</article-title>
<source>Genitourin Med</source>. <year>1987</year>;<volume>63</volume>:<fpage>326</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/sti.63.5.326</pub-id><?supplied-pmid 3500110?><pub-id pub-id-type="pmid">3500110</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Corwin</surname><given-names>AL</given-names></name><name><surname>Constantine</surname><given-names>NT</given-names></name><name><surname>Omar</surname><given-names>MA</given-names></name><name><surname>Guled</surname><given-names>A</given-names></name><name><surname>Yusef</surname><given-names>M</given-names></name><etal/></person-group><article-title>Low prevalence of human immunodeficiency virus-1 (HIV-1), HIV-2, and human T cell lymphotropic virus-1 infection in Somalia.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1991</year>;<volume>45</volume>:<fpage>653</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.1991.45.653</pub-id><?supplied-pmid 1763791?><pub-id pub-id-type="pmid">1763791</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corwin</surname><given-names>AL</given-names></name><name><surname>Olson</surname><given-names>JG</given-names></name><name><surname>Omar</surname><given-names>MA</given-names></name><name><surname>Razaki</surname><given-names>A</given-names></name><name><surname>Watts</surname><given-names>DM</given-names></name></person-group><article-title>HIV-1 in Somalia: Prevalence and knowledge among prostitutes.</article-title>
<source>AIDS</source>. <year>1991</year>;<volume>5</volume>:<fpage>902</fpage>-<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1097/00002030-199107000-00023</pub-id><?supplied-pmid 1892603?><pub-id pub-id-type="pmid">1892603</pub-id></mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>DM</given-names></name><name><surname>Corwin</surname><given-names>AL</given-names></name><name><surname>Omar</surname><given-names>MA</given-names></name><name><surname>Hyams</surname><given-names>KC</given-names></name></person-group><article-title>Low risk of sexual transmission of hepatitis C virus in Somalia.</article-title>
<source>Trans R Soc Trop Med Hyg</source>. <year>1994</year>;<volume>88</volume>:<fpage>55</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0035-9203(94)90495-2</pub-id><?supplied-pmid 8154002?><pub-id pub-id-type="pmid">8154002</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="book">International Organization for Migration (IOM). Integrated biological and behavioural surveillance survey among vulnerable women in Hargeisa, Somaliland. Geneva, Switzerland: 2017.</mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="book">Government of the Republic of South Sudan-Ministry of Health. A bio-behavioral HIV survey of female sex workers in South Sudan. South Sudan: 2016.</mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bchir</surname><given-names>A</given-names></name><name><surname>Jemni</surname><given-names>L</given-names></name><name><surname>Saadi</surname><given-names>M</given-names></name><name><surname>Milovanovic</surname><given-names>A</given-names></name><name><surname>Brahim</surname><given-names>H</given-names></name><name><surname>Catalan</surname><given-names>F</given-names></name></person-group><article-title>Markers of sexually transmitted diseases in prostitutes in central Tunisia.</article-title>
<source>Genitourin Med</source>. <year>1988</year>;<volume>64</volume>:<fpage>396</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/sti.64.6.396-a</pub-id><?supplied-pmid 3224977?><pub-id pub-id-type="pmid">3224977</pub-id></mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayachi</surname><given-names>F</given-names></name><name><surname>Kechrid</surname><given-names>A</given-names></name><name><surname>Lagha</surname><given-names>N</given-names></name><name><surname>Ben Hamida</surname><given-names>A</given-names></name><name><surname>Amamou</surname><given-names>H</given-names></name><name><surname>Ben Mahmoud</surname><given-names>R</given-names></name></person-group><article-title>Seroprevalence rate of syphilis in 3 groups of sexually active tunisian women.</article-title>
<comment>[French]</comment>
<source>Med Mal Infect</source>. <year>1997</year>;<volume>27</volume>:<fpage>913</fpage>-<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0399-077X(97)80249-1</pub-id></mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="book">Stulhofer A, Bozicevic I. HIV bio-behavioural survey among female sex workers in Aden, Yemen. 2008.</mixed-citation></ref><ref id="R65"><label>65</label><mixed-citation publication-type="book">National AIDS Control Program, Johns Hopkins University Bloomberg School of Public Health HIV Surveillance Project. Integrated behavioral &#x00026; biological surveillance (IBBS) in Afghanistan: Year 1 report. Kabul, Afghanistan: 2010.</mixed-citation></ref><ref id="R66"><label>66</label><mixed-citation publication-type="book">National AIDS Control Program, Johns Hopkins University Bloomberg School of Public Health HIV Surveillance Project. Integrated biological &#x00026; behavioral surveillance (IBBS) in selected cities of Afghanistan: Findings of 2012 IBBS survey and comparison to 2009 IBBS survey. Kabul, Afghanistan: National AIDS Control Program; 2012.</mixed-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="book">Ministere de la Sante et de la Population et de la Reforme Hospitaliere. Direction de la Prevention Comite National de Lutte contre les IST/VIH/SIDA. Plan national strategique de lutte contre les IST/VIH/Sida 2008-2012. Geneva, Switzerland: Ministere de la Sante et de la Population et de la Reforme Hospitaliere; 2009.</mixed-citation></ref><ref id="R68"><label>68</label><mixed-citation publication-type="confproc">Mirzazadeh A, Shokoohi M, Khajehkazemi R, et al, editors. HIV and sexually transmitted infections among female sex workers in Iran: Findings from the 2010 and 2015 national surveillance surveys. 21st International AIDS Conference, Durban, South Africa, 7/18-22, ePoster, Abstract TUPEC175; 2016.</mixed-citation></ref><ref id="R69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibi</surname><given-names>I</given-names></name><name><surname>Devrajani</surname><given-names>BR</given-names></name><name><surname>Shah</surname><given-names>SZA</given-names></name><name><surname>Soomro</surname><given-names>MH</given-names></name><name><surname>Jatoi</surname><given-names>MA</given-names></name></person-group><article-title>Frequency of syphilis in female sex workers at red light area of Hyderabad, Pakistan.</article-title>
<source>J Pak Med Assoc</source>. <year>2010</year>;<volume>60</volume>:<fpage>353</fpage>-<lpage>6</lpage>.<?supplied-pmid 20527605?><pub-id pub-id-type="pmid">20527605</pub-id></mixed-citation></ref><ref id="R70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raza</surname><given-names>M</given-names></name><name><surname>Ikram</surname><given-names>N</given-names></name><name><surname>Saeed</surname><given-names>N</given-names></name><name><surname>Waheed</surname><given-names>U</given-names></name><name><surname>Kamran</surname><given-names>M</given-names></name><name><surname>Iqbal</surname><given-names>R</given-names></name><etal/></person-group><article-title>HIV/AIDS and syphilis screening among high risk groups.</article-title>
<source>J Rawal Med Coll.</source>
<year>2015</year>;<volume>19</volume>:<fpage>11</fpage>-<lpage>4</lpage>.</mixed-citation></ref><ref id="R71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burans</surname><given-names>JP</given-names></name><name><surname>Fox</surname><given-names>E</given-names></name><name><surname>Omar</surname><given-names>MA</given-names></name><name><surname>Farah</surname><given-names>AH</given-names></name><name><surname>Abbass</surname><given-names>S</given-names></name><name><surname>Yusef</surname><given-names>S</given-names></name><etal/></person-group><article-title>HIV infection surveillance in Mogadishu, Somalia.</article-title>
<source>East Afr Med J</source>. <year>1990</year>;<volume>67</volume>:<fpage>466</fpage>-<lpage>72</lpage>.<?supplied-pmid 2226225?><pub-id pub-id-type="pmid">2226225</pub-id></mixed-citation></ref><ref id="R72"><label>72</label><mixed-citation publication-type="other">Sudan National AIDS Control Program. Integrated bio-behavioral HIV surveillance (IBBS) among female sex workers and men who have sex with men in 15 states of Sudan, 2011-2012. 2012.</mixed-citation></ref><ref id="R73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Znazen</surname><given-names>A</given-names></name><name><surname>Frikha-Gargouri</surname><given-names>O</given-names></name><name><surname>Berrajah</surname><given-names>L</given-names></name><name><surname>Bellalouna</surname><given-names>S</given-names></name><name><surname>Hakim</surname><given-names>H</given-names></name><name><surname>Gueddana</surname><given-names>N</given-names></name><etal/></person-group><article-title>Sexually transmitted infections among female sex workers in Tunisia: High prevalence of Chlamydia trachomatis.</article-title>
<source>Sex Transm Infect</source>. <year>2010</year>;<volume>86</volume>:<fpage>500</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/sti.2010.042770</pub-id><?supplied-pmid 20656718?><pub-id pub-id-type="pmid">20656718</pub-id></mixed-citation></ref><ref id="R74"><label>74</label><mixed-citation publication-type="other">Additional country-level data provided through the MENA HIV/AIDS Epidemiology Synthesis Project database by the World Health Organization Regional Office for the Eastern Mediterranean. 2013.</mixed-citation></ref><ref id="R75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moayedi-Nia</surname><given-names>S</given-names></name><name><surname>Bayat Jozani</surname><given-names>Z</given-names></name><name><surname>Esmaeeli Djavid</surname><given-names>G</given-names></name><name><surname>Entekhabi</surname><given-names>F</given-names></name><name><surname>Bayanolhagh</surname><given-names>S</given-names></name><name><surname>Saatian</surname><given-names>M</given-names></name><etal/></person-group><article-title>HIV, HCV, HBV, HSV, and syphilis prevalence among female sex workers in Tehran, Iran, by using respondent-driven sampling.</article-title>
<source>AIDS Care</source>. <year>2016</year>;<volume>28</volume>:<fpage>487</fpage>-<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1080/09540121.2015.1109582</pub-id><?supplied-pmid 26565671?><pub-id pub-id-type="pmid">26565671</pub-id></mixed-citation></ref><ref id="R76"><label>76</label><mixed-citation publication-type="book">Khattabi H, Alami K. Surveillance sentinelle du VIH: Resultats 2004 et tendances de la seroprevalence du VIH. Morocco: 2005.</mixed-citation></ref><ref id="R77"><label>77</label><mixed-citation publication-type="other">Bennani A., Alami K. Surveillance sentinelle du VIH: Resultats 2005 et tendances de la seroprevalence du VIH. 2006.</mixed-citation></ref><ref id="R78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadi</surname><given-names>Z</given-names></name><name><surname>Bouguermouh</surname><given-names>A</given-names></name><name><surname>Ait-Mokhtar</surname><given-names>N</given-names></name><name><surname>Allouache</surname><given-names>A</given-names></name><name><surname>Ziat</surname><given-names>A</given-names></name><name><surname>Orfilla</surname><given-names>J</given-names></name></person-group><article-title>Genital chlamydia infections. A seroepidemiologic study in Algiers.</article-title>
<comment>[French]</comment>. <source>Arch Inst Pasteur Alger</source>. <year>1989</year>;<volume>57</volume>:<fpage>73</fpage>-<lpage>82</lpage>.<?supplied-pmid 2489406?><pub-id pub-id-type="pmid">2489406</pub-id></mixed-citation></ref><ref id="R79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darougar</surname><given-names>S</given-names></name><name><surname>Aramesh</surname><given-names>B</given-names></name><name><surname>Gibson</surname><given-names>JA</given-names></name><name><surname>Treharne</surname><given-names>JD</given-names></name><name><surname>Jones</surname><given-names>BR</given-names></name></person-group><article-title>Chlamydial genital infection in prostitutes in Iran.</article-title>
<source>Br J Vener Dis</source>. <year>1983</year>;<volume>59</volume>:<fpage>53</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/sti.59.1.53</pub-id><?supplied-pmid 6824908?><pub-id pub-id-type="pmid">6824908</pub-id></mixed-citation></ref><ref id="R80"><label>80</label><mixed-citation publication-type="book">World Health Organization. HIV surveillance systems: Regional update 2011. Geneva: WHO; 2011.</mixed-citation></ref><ref id="R81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasirian</surname><given-names>M</given-names></name><name><surname>Kianersi</surname><given-names>S</given-names></name><name><surname>Hoseini</surname><given-names>SG</given-names></name><name><surname>Kassaian</surname><given-names>N</given-names></name><name><surname>Yaran</surname><given-names>M</given-names></name><name><surname>Shoaei</surname><given-names>P</given-names></name><etal/></person-group><article-title>Prevalence of sexually transmitted infections and their risk factors among female sex workers in Isfahan, Iran: A cross-sectional study.</article-title>
<source>J Int Assoc Provid AIDS Care</source>. <year>2017</year>;<volume>16</volume>:<fpage>608</fpage>-<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1177/2325957417732836</pub-id><?supplied-pmid 29017374?><pub-id pub-id-type="pmid">29017374</pub-id></mixed-citation></ref><ref id="R82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taghizadeh</surname><given-names>H</given-names></name><name><surname>Taghizadeh</surname><given-names>F</given-names></name><name><surname>Fathi</surname><given-names>M</given-names></name><name><surname>Reihani</surname><given-names>P</given-names></name><name><surname>Shirdel</surname><given-names>N</given-names></name><name><surname>Rezaee</surname><given-names>SM</given-names></name></person-group><article-title>Drug use and high-risk sexual behaviors of women at a drop-in center in mazandaran province, Iran, 2014.</article-title>
<source>IJPBS</source>. <year>2015</year>;<volume>9</volume>:<fpage>e1047</fpage>-<lpage>55</lpage>. <pub-id pub-id-type="doi">10.17795/ijpbs1047</pub-id><?supplied-pmid 26288640?><pub-id pub-id-type="pmid">26288640</pub-id></mixed-citation></ref><ref id="R83"><label>83</label><mixed-citation publication-type="other">Programme de Lutte contre les IST/SIDA. Analyse de la situation et de la reponse au VIH/SIDA en Tunisie. Tunisia: 2005.</mixed-citation></ref><ref id="R84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vafaei</surname><given-names>H</given-names></name><name><surname>Asadi</surname><given-names>N</given-names></name><name><surname>Foroughinia</surname><given-names>L</given-names></name><name><surname>Salehi</surname><given-names>A</given-names></name><name><surname>Kuhnavard</surname><given-names>S</given-names></name><name><surname>Akbarzadeh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of abnormal cervical cytology from HIV positive women, female sex workers, and general population.</article-title>
<source>IJCBNM</source>. <year>2015</year>;<volume>3</volume>:<fpage>76</fpage>-<lpage>83</lpage>.<?supplied-pmid 26005687?><pub-id pub-id-type="pmid">26005687</pub-id></mixed-citation></ref><ref id="R85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>AI</given-names></name><name><surname>Kouwatli</surname><given-names>KM</given-names></name><name><surname>Obeid</surname><given-names>MT</given-names></name></person-group><article-title>Frequency of herpes simplex virus in Syria based on type-specific serological assay.</article-title>
<source>Saudi Med J</source>. <year>2000</year>;<volume>21</volume>:<fpage>355</fpage>-<lpage>60</lpage>.<?supplied-pmid 11533818?><pub-id pub-id-type="pmid">11533818</pub-id></mixed-citation></ref><ref id="R86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smolak</surname><given-names>A</given-names></name><name><surname>Rowley</surname><given-names>J</given-names></name><name><surname>Nagelkerke</surname><given-names>N</given-names></name><name><surname>Kassebaum</surname><given-names>NJ</given-names></name><name><surname>Chico</surname><given-names>RM</given-names></name><name><surname>Korenromp</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Trends and predictors of syphilis prevalence in the general population: Global pooled analyses of 1103 prevalence measures including 136 million syphilis tests.</article-title>
<source>Clin Infect Dis</source>. <year>2018</year>;<volume>66</volume>:<fpage>1184</fpage>-<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cix975</pub-id><?supplied-pmid 29136161?><pub-id pub-id-type="pmid">29136161</pub-id></mixed-citation></ref><ref id="R87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozicevic</surname><given-names>I</given-names></name><name><surname>Riedner</surname><given-names>G</given-names></name><name><surname>Calleja</surname><given-names>JM</given-names></name></person-group><article-title>HIV surveillance in MENA: Recent developments and results.</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>
<issue>Suppl 3</issue>:<fpage>iii11</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2012-050849</pub-id><?supplied-pmid 23434789?><pub-id pub-id-type="pmid">23434789</pub-id></mixed-citation></ref><ref id="R88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandepitte</surname><given-names>J</given-names></name><name><surname>Lyerla</surname><given-names>R</given-names></name><name><surname>Dallabetta</surname><given-names>G</given-names></name><name><surname>Crabbe</surname><given-names>F</given-names></name><name><surname>Alary</surname><given-names>M</given-names></name><name><surname>Buve</surname><given-names>A</given-names></name></person-group><article-title>Estimates of the number of female sex workers in different regions of the world.</article-title>
<source>Sex Transm Infect</source>. <year>2006</year>;<volume>82</volume>
<issue>Suppl 3</issue>:<fpage>iii18</fpage>-<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1136/sti.2006.020081</pub-id><?supplied-pmid 16735288?><pub-id pub-id-type="pmid">16735288</pub-id></mixed-citation></ref><ref id="R89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouyoumjian</surname><given-names>SP</given-names></name><name><surname>El Rhilani</surname><given-names>H</given-names></name><name><surname>Latifi</surname><given-names>A</given-names></name><name><surname>El Kettani</surname><given-names>A</given-names></name><name><surname>Chemaitelly</surname><given-names>H</given-names></name><name><surname>Alami</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mapping of new HIV infections in Morocco and impact of select interventions.</article-title>
<source>IJID</source>. <year>2018</year>;<volume>68</volume>:<fpage>4</fpage>-<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2017.12.013</pub-id><?supplied-pmid 29253710?><pub-id pub-id-type="pmid">29253710</pub-id></mixed-citation></ref><ref id="R90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumtaz</surname><given-names>GR</given-names></name><name><surname>Riedner</surname><given-names>G</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>The emerging face of the HIV epidemic in the Middle East and North Africa.</article-title>
<source>Curr Opin HIV AIDS</source>. <year>2014</year>;<volume>9</volume>:<fpage>183</fpage>-<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1097/COH.0000000000000038</pub-id><?supplied-pmid 24445372?><pub-id pub-id-type="pmid">24445372</pub-id></mixed-citation></ref><ref id="R91"><label>91</label><mixed-citation publication-type="book">World Health Organization. Strategies and laboratory methods for strengthening surveillance of sexually transmitted infections 2012. Geneva, Switzerland: World Health Organization, 2012.</mixed-citation></ref><ref id="R92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>M</given-names></name><name><surname>Holte-McKenzie</surname><given-names>M</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Archibald</surname><given-names>CP</given-names></name><name><surname>Blanchard</surname><given-names>JF</given-names></name><name><surname>Thompson</surname><given-names>LH</given-names></name></person-group><article-title>Second generation HIV surveillance in Pakistan: Policy challenges and opportunities.</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>:<fpage>ii48</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2012-050773</pub-id><?supplied-pmid 23220785?><pub-id pub-id-type="pmid">23220785</pub-id></mixed-citation></ref><ref id="R93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reintjes</surname><given-names>R</given-names></name><name><surname>Wiessing</surname><given-names>L</given-names></name></person-group><article-title>2nd-generation HIV surveillance and injecting drug use: Uncovering the epidemiological ice-berg.</article-title>
<source>Int J Public Health</source>. <year>2007</year>;<volume>52</volume>:<fpage>166</fpage>-<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s00038-007-5123-0</pub-id><?supplied-pmid 17958283?><pub-id pub-id-type="pmid">17958283</pub-id></mixed-citation></ref><ref id="R94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awad</surname><given-names>SF</given-names></name><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s?</article-title>
<source>Epidemics</source>. <year>2014</year>;<volume>8</volume>:<fpage>9</fpage>-<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2014.06.001</pub-id><?supplied-pmid 25240899?><pub-id pub-id-type="pmid">25240899</pub-id></mixed-citation></ref><ref id="R95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>CR</given-names></name><name><surname>Osbak</surname><given-names>K</given-names></name><name><surname>Buyze</surname><given-names>J</given-names></name><name><surname>Chico</surname><given-names>RM</given-names></name></person-group><article-title>The changing relationship between bacterial STIs and HIV prevalence in South Africa - an ecological study.</article-title>
<source>Int J STD AIDS</source>. <year>2015</year>;<volume>26</volume>:<fpage>556</fpage>-<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1177/0956462414546392</pub-id><?supplied-pmid 25122576?><pub-id pub-id-type="pmid">25122576</pub-id></mixed-citation></ref><ref id="R96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osbak</surname><given-names>KK</given-names></name><name><surname>Rowley</surname><given-names>JT</given-names></name><name><surname>Kassebaum</surname><given-names>NJ</given-names></name><name><surname>Kenyon</surname><given-names>CR</given-names></name></person-group><article-title>The prevalence of syphilis from the early HIV period is correlated With peak HIV prevalence at a country level.</article-title>
<source>Sex Transm Dis</source>. <year>2016</year>;<volume>43</volume>:<fpage>255</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/OLQ.0000000000000422</pub-id><?supplied-pmid 26967303?><pub-id pub-id-type="pmid">26967303</pub-id></mixed-citation></ref><ref id="R97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>CR</given-names></name><name><surname>Osbak</surname><given-names>K</given-names></name><name><surname>Tsoumanis</surname><given-names>A</given-names></name></person-group><article-title>The global epidemiology of syphilis in the past century - a systematic review based on antenatal syphilis prevalence.</article-title>
<source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>:<elocation-id>e0004711</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0004711</pub-id><?supplied-pmid 27167068?><pub-id pub-id-type="pmid">27167068</pub-id></mixed-citation></ref><ref id="R98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>JD</given-names></name><name><surname>Cohen</surname><given-names>MS</given-names></name></person-group><article-title>China&#x02019;s syphilis epidemic: epidemiology, proximate determinants of spread, and control responses.</article-title>
<source>Curr Opin Infect Dis</source>. <year>2011</year>;<volume>24</volume>:<fpage>50</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0b013e32834204bf</pub-id><?supplied-pmid 21150594?><pub-id pub-id-type="pmid">21150594</pub-id></mixed-citation></ref><ref id="R99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamm</surname><given-names>LV</given-names></name></person-group><article-title>Global challenge of antibiotic-resistant Treponema pallidum.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2010</year>;<volume>54</volume>:<fpage>583</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01095-09</pub-id><?supplied-pmid 19805553?><pub-id pub-id-type="pmid">19805553</pub-id></mixed-citation></ref><ref id="R100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammed</surname><given-names>H</given-names></name><name><surname>Mitchell</surname><given-names>H</given-names></name><name><surname>Sile</surname><given-names>B</given-names></name><name><surname>Duffell</surname><given-names>S</given-names></name><name><surname>Nardone</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>G</given-names></name></person-group><article-title>Increase in sexually transmitted infections among men who have sex with men, England, 2014.</article-title>
<source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>:<fpage>88</fpage>-<lpage>91</lpage>. <pub-id pub-id-type="doi">10.3201/eid2201.151331</pub-id><?supplied-pmid 26689861?><pub-id pub-id-type="pmid">26689861</pub-id></mixed-citation></ref><ref id="R101"><label>101</label><mixed-citation publication-type="book">Centers for Disease Control and Prevention. Increase in incidence of congenital syphilis &#x02014; United States, 2012&#x02013;2014. Atlanta, USA: 2015.</mixed-citation></ref><ref id="R102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>ZQ</given-names></name><name><surname>Zhang</surname><given-names>GC</given-names></name><name><surname>Gong</surname><given-names>XD</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Syphilis in China: Results of a national surveillance programme.</article-title>
<source>Lancet</source>. <year>2007</year>;<volume>369</volume>:<fpage>132</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60074-9</pub-id><?supplied-pmid 17223476?><pub-id pub-id-type="pmid">17223476</pub-id></mixed-citation></ref><ref id="R103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>JD</given-names></name><name><surname>Cohen</surname><given-names>MS</given-names></name></person-group><article-title>China&#x02019;s syphilis epidemic: Epidemiology, proximate determinants of spread, and control responses.</article-title>
<source>Curr Opin Infect Dis</source>. <year>2011</year>;<volume>24</volume>:<fpage>50</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0b013e32834204bf</pub-id><?supplied-pmid 21150594?><pub-id pub-id-type="pmid">21150594</pub-id></mixed-citation></ref><ref id="R104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoltey</surname><given-names>JE</given-names></name><name><surname>Cohen</surname><given-names>SE</given-names></name></person-group><article-title>Syphilis transmission: a review of the current evidence.</article-title>
<source>Sex Health</source>. <year>2015</year>;<volume>12</volume>:<fpage>103</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1071/SH14174</pub-id><?supplied-pmid 25702043?><pub-id pub-id-type="pmid">25702043</pub-id></mixed-citation></ref><ref id="R105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Thani</surname><given-names>A</given-names></name><name><surname>Abdul-Rahim</surname><given-names>H</given-names></name><name><surname>Alabsi</surname><given-names>E</given-names></name><name><surname>Bsaisu</surname><given-names>HN</given-names></name><name><surname>Haddad</surname><given-names>P</given-names></name><name><surname>Mumtaz</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Prevalence of Chlamydia trachomatis infection in the general population of women in Qatar.</article-title>
<source>Sex Transm Infect</source>. <year>2013</year>;<volume>89</volume>:<fpage>iii57</fpage>-<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2013-051169</pub-id><?supplied-pmid 23863874?><pub-id pub-id-type="pmid">23863874</pub-id></mixed-citation></ref><ref id="R106"><label>106</label><mixed-citation publication-type="book">Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wislon D, Tawil O. Policy notes. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO publication. Washington DC: The World Bank Press; 2010.</mixed-citation></ref><ref id="R107"><label>107</label><mixed-citation publication-type="book">Jenkins C, Robalino DA. HIV/AIDS in the Middle East and North Africa: The costs of inaction. Washigton, D.C.: The World Bank; 2003.</mixed-citation></ref><ref id="R108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebbi</surname><given-names>MR</given-names></name></person-group><article-title>Female sex workers and fear of stigmatisation</article-title>
<comment>[2]</comment>. <source>Sex Transm Infect</source>. <year>2005</year>;<volume>81</volume>:<fpage>180</fpage>-<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1136/sti.2004.010512</pub-id><?supplied-pmid 15800100?><pub-id pub-id-type="pmid">15800100</pub-id></mixed-citation></ref><ref id="R109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejong</surname><given-names>J</given-names></name><name><surname>Mortagy</surname><given-names>I</given-names></name></person-group><article-title>The struggle for recognition by people living with HIV/AIDS in Sudan.</article-title>
<source>Qual Health Res</source>. <year>2013</year>;<volume>23</volume>:<fpage>782</fpage>-<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1177/1049732313482397</pub-id><?supplied-pmid 23515299?><pub-id pub-id-type="pmid">23515299</pub-id></mixed-citation></ref><ref id="R110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJong</surname><given-names>J</given-names></name><name><surname>Mahfoud</surname><given-names>Z</given-names></name><name><surname>Khoury</surname><given-names>D</given-names></name><name><surname>Barbir</surname><given-names>F</given-names></name><name><surname>Afifi</surname><given-names>RA</given-names></name></person-group><article-title>Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: Illustrations from Lebanon.</article-title>
<source>Am J Public Health</source>. <year>2009</year>;<volume>99</volume>:<fpage>1562</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2008.144832</pub-id><?supplied-pmid 19608961?><pub-id pub-id-type="pmid">19608961</pub-id></mixed-citation></ref><ref id="R111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayaud</surname><given-names>P</given-names></name><name><surname>Mabey</surname><given-names>D</given-names></name></person-group><article-title>Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges.</article-title>
<source>Sex Transm Infect</source>. <year>2004</year>;<volume>80</volume>:<fpage>174</fpage>-<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1136/sti.2002.004101</pub-id><?supplied-pmid 15169997?><pub-id pub-id-type="pmid">15169997</pub-id></mixed-citation></ref><ref id="R112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grund</surname><given-names>JM</given-names></name><name><surname>Bryant</surname><given-names>TS</given-names></name><name><surname>Jackson</surname><given-names>I</given-names></name><name><surname>Curran</surname><given-names>K</given-names></name><name><surname>Bock</surname><given-names>N</given-names></name><name><surname>Toledo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Association between male circumcision and women&#x02019;s biomedical health outcomes: A systematic review.</article-title>
<source>Lancet Glob Health</source>. <year>2017</year>;<volume>5</volume>:<fpage>e1113</fpage>-<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(17)30369-8</pub-id><?supplied-pmid 29025633?><pub-id pub-id-type="pmid">29025633</pub-id></mixed-citation></ref><ref id="R113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>BJ</given-names></name><name><surname>Hankins</surname><given-names>CA</given-names></name></person-group><article-title>Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women.</article-title>
<source>Lancet Glob Health</source>. <year>2017</year>;<volume>5</volume>:<fpage>e1054</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(17)30386-8</pub-id><?supplied-pmid 29025620?><pub-id pub-id-type="pmid">29025620</pub-id></mixed-citation></ref><ref id="R114"><label>114</label><mixed-citation publication-type="book">World Health Organization. Implementing comprehensive HIV/STI programmes with sex workers. Geneva, Switzerland: WHO; 2013.</mixed-citation></ref><ref id="R115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wi</surname><given-names>T</given-names></name><name><surname>Lahra</surname><given-names>MM</given-names></name><name><surname>Ndowa</surname><given-names>F</given-names></name><name><surname>Bala</surname><given-names>M</given-names></name><name><surname>Dillon</surname><given-names>JR</given-names></name><name><surname>Ramon-Pardo</surname><given-names>P</given-names></name><etal/></person-group><article-title>Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.</article-title>
<source>PLoS Med</source>. <year>2017</year>;<volume>14</volume>:<elocation-id>e1002344</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002344</pub-id><?supplied-pmid 28686231?><pub-id pub-id-type="pmid">28686231</pub-id></mixed-citation></ref><ref id="R116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group><article-title>Global resistance of Neisseria gonorrhoeae: When theory becomes reality.</article-title>
<source>Curr Opin Infect Dis</source>. <year>2014</year>;<volume>27</volume>:<fpage>62</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0000000000000025</pub-id><?supplied-pmid 24275696?><pub-id pub-id-type="pmid">24275696</pub-id></mixed-citation></ref><ref id="R117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolan</surname><given-names>GA</given-names></name><name><surname>Sparling</surname><given-names>PF</given-names></name><name><surname>Wasserheit</surname><given-names>JN</given-names></name></person-group><article-title>The emerging threat of untreatable gonococcal infection.</article-title>
<source>N Engl J Med</source>. <year>2012</year>;<volume>366</volume>:<fpage>485</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp1112456</pub-id><?supplied-pmid 22316442?><pub-id pub-id-type="pmid">22316442</pub-id></mixed-citation></ref><ref id="R118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkcaldy</surname><given-names>RD</given-names></name><name><surname>Harvey</surname><given-names>A</given-names></name><name><surname>Papp</surname><given-names>JR</given-names></name><name><surname>Del Rio</surname><given-names>C</given-names></name><name><surname>Soge</surname><given-names>OO</given-names></name><name><surname>Holmes</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Neisseria gonorrhoeae antimicrobial susceptibility surveillance - The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014.</article-title>
<source>MMWR Surveill Summ</source>. <year>2016</year>;<volume>65</volume>:<fpage>1</fpage>-<lpage>19</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.ss6507a1</pub-id><?supplied-pmid 27414503?><pub-id pub-id-type="pmid">27414503</pub-id></mixed-citation></ref><ref id="R119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suay-Garcia</surname><given-names>B</given-names></name><name><surname>Perez-Gracia</surname><given-names>MT</given-names></name></person-group><article-title>Future prospects for Neisseria gonorrhoeae treatment.</article-title>
<source>Antibiotics (Basel)</source>. <year>2018</year>;<volume>7</volume>:<elocation-id>E49</elocation-id>. <pub-id pub-id-type="doi">10.3390/antibiotics7020049</pub-id><?supplied-pmid 29914071?><pub-id pub-id-type="pmid">29914071</pub-id></mixed-citation></ref><ref id="R120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>PR</given-names></name><name><surname>Gwanzura</surname><given-names>L</given-names></name><name><surname>Latif</surname><given-names>AS</given-names></name><name><surname>Marowa</surname><given-names>E</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Katzenstein</surname><given-names>DA</given-names></name></person-group><article-title>Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.</article-title>
<source>Int J Antimicrob Agents</source>. <year>1997</year>;<volume>9</volume>:<fpage>175</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0924-8579(97)00052-6</pub-id><?supplied-pmid 9552714?><pub-id pub-id-type="pmid">9552714</pub-id></mixed-citation></ref><ref id="R121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ssemwanga</surname><given-names>D</given-names></name><name><surname>Ndembi</surname><given-names>N</given-names></name><name><surname>Lyagoba</surname><given-names>F</given-names></name><name><surname>Magambo</surname><given-names>B</given-names></name><name><surname>Kapaata</surname><given-names>A</given-names></name><name><surname>Bukenya</surname><given-names>J</given-names></name><etal/></person-group><article-title>Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda.</article-title>
<source>Clin Infect Dis</source>. <year>2012</year>;<volume>54</volume>
<issue>Suppl 4</issue>:<fpage>S339</fpage>-<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cir937</pub-id><?supplied-pmid 22544200?><pub-id pub-id-type="pmid">22544200</pub-id></mixed-citation></ref><ref id="R122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraha</surname><given-names>M</given-names></name><name><surname>Egli-Gany</surname><given-names>D</given-names></name><name><surname>Low</surname><given-names>N</given-names></name></person-group><article-title>Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review.</article-title>
<source>F1000Res</source>. <year>2018</year>;<volume>7</volume>:<fpage>400</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.13600.1</pub-id><?supplied-pmid 29636908?><pub-id pub-id-type="pmid">29636908</pub-id></mixed-citation></ref><ref id="R123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>SL</given-names></name><name><surname>Low</surname><given-names>N</given-names></name><name><surname>Newman</surname><given-names>LM</given-names></name><name><surname>Bolan</surname><given-names>G</given-names></name><name><surname>Kamb</surname><given-names>M</given-names></name><name><surname>Broutet</surname><given-names>N</given-names></name></person-group><article-title>Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.</article-title>
<source>Vaccine</source>. <year>2014</year>;<volume>32</volume>:<fpage>1527</fpage>-<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.07.087</pub-id><?supplied-pmid 24581979?><pub-id pub-id-type="pmid">24581979</pub-id></mixed-citation></ref><ref id="R124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>SL</given-names></name><name><surname>Deal</surname><given-names>CD</given-names></name><name><surname>Giersing</surname><given-names>B</given-names></name><name><surname>Rees</surname><given-names>H</given-names></name><name><surname>Bolan</surname><given-names>G</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name><etal/></person-group><article-title>The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.</article-title>
<source>Vaccine</source>. <year>2016</year>;<volume>34</volume>:<fpage>2939</fpage>-<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.03.111</pub-id><?supplied-pmid 27105564?><pub-id pub-id-type="pmid">27105564</pub-id></mixed-citation></ref><ref id="R125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broutet</surname><given-names>N</given-names></name><name><surname>Fruth</surname><given-names>U</given-names></name><name><surname>Deal</surname><given-names>C</given-names></name><name><surname>Gottlieb</surname><given-names>SL</given-names></name><name><surname>Rees</surname><given-names>H</given-names></name></person-group><article-title>participants of the STIVTC. Vaccines against sexually transmitted infections: the way forward.</article-title>
<source>Vaccine</source>. <year>2014</year>;<volume>32</volume>:<fpage>1630</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.01.053</pub-id><?supplied-pmid 24480024?><pub-id pub-id-type="pmid">24480024</pub-id></mixed-citation></ref><ref id="R126"><label>126</label><mixed-citation publication-type="other">World Health Organization Office for the Eastern Mediterranean Region (WHO-EMRO). Technical paper on the regional strategy for STI prevention and control in the Eastern Mediterranean Region of WHO presented at the regional committee 55. Unpublished.</mixed-citation></ref></ref-list></back></article>